James T. Willerson

James T. Willerson's AcademicInfluence.com Rankings

James T. Willerson

Philosophy

#2192

World Rank

#3805

Historical Rank

Logic

#478

World Rank

#892

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is James T. Willerson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James T. Willerson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (2008) (4914)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells (2000) (2015)
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial (2003) (1391)
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure (2003) (1367)
Inflammation as a Cardiovascular Risk Factor (2004) (1277)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
Endothelial dysfunction. (2003) (1195)
The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis (2003) (1038)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009) (989)
Appointment of New Associate Editor for Circulation (1996) (927)
Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs (2001) (877)
Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model (2005) (797)
Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* (1987) (739)
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. (2009) (695)
Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. (1981) (634)
Leukocyte count and coronary heart disease: implications for risk assessment. (2004) (628)
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. (2006) (564)
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. (2000) (546)
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells (2003) (540)
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis☆ (1989) (527)
Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications (1989) (509)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (481)
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. (2012) (453)
Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo (2003) (452)
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. (1991) (439)
Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. (1987) (436)
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. (2009) (436)
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. (1991) (434)
Left Ventricular Performance in Normal Subjects: A Comparison of the Responses to Exercise in the Upright and Supine Positions (1980) (422)
Coming of age of C-reactive protein: using inflammation markers in cardiology. (2003) (414)
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. (2011) (411)
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. (1988) (402)
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. (2012) (399)
Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy (2004) (395)
Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations: Main Results of the GUARDIAN Trial (2000) (393)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
Hippo signaling impedes adult heart regeneration (2013) (362)
A New Method for Radionuclide Imaging of Acute Myocardial Infarction in Humans (1974) (349)
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. (2006) (346)
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. (1995) (346)
Dissecting aneurysm of the aorta: aortographic features affecting prognosis. (1972) (323)
Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways (2004) (320)
Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. (2007) (304)
Accumulation of Unesterified Arachidonic Acid in Ischemic Canine Myocardium: Relationship to a Phosphatidylcholine Deacylation‐Reacylation Cycle and the Depletion of Membrane Phospholipids (1984) (303)
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. (2005) (303)
LABORATORY INVESTIGATION (2005) (302)
Nongeometric determination of left ventricular volumes from equilibrium blood pool scans. (1980) (278)
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. (1996) (271)
Hippo Pathway Deficiency Reverses Systolic Heart Failure Post-Infarction (2017) (270)
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial (2002) (264)
Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. (1988) (255)
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. (1989) (251)
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. (2014) (250)
Vulnerable Atherosclerotic Plaque: A Multifocal Disease (2003) (248)
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. (1989) (239)
Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. (1975) (238)
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. (1998) (233)
Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. (1989) (232)
Use of A Direct Antithrombin, Hirulog, in Place of Heparin During Coronary Angioplast (1993) (227)
The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy (2014) (219)
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. (2008) (219)
Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. (1989) (219)
Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report From the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial (2004) (216)
The Prognostic Value of Submaximal Exercise Testing with Radionuclide Ventriculography Before Hospital Discharge in Patients with Recent Myocardial Infarction (1981) (215)
Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. (1977) (212)
C-reactive protein: linking inflammation to cardiovascular complications. (2001) (210)
Role of inflammation in coronary plaque disruption. (1994) (210)
Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-Positive Cells Into Cardiomyocytes In Vivo (2004) (202)
Phospholipid Alterations in Canine Ischemic Myocardium: Temporal and Topographical Correlations with Tc‐99m‐PPi Accumulation and an in Vitro Sarcolemmal Ca2+ Permeability Defect (1981) (201)
Endogenous Nitric Oxide Protects Against Platelet Aggregation and Cyclic Flow Variations in Stenosed and Endothelium‐Injured Arteries (1992) (201)
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. (1986) (200)
Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. (1986) (200)
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors (2012) (199)
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. (2016) (195)
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. (1984) (195)
Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. (1972) (192)
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease (2003) (189)
Increased Urinary Leukotriene Excretion in Patients With Cardiac Ischemia: In Vivo Evidence for 5‐Lipoxygenase Activation (1992) (188)
Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy (2007) (187)
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). (2011) (184)
Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. (1976) (183)
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. (2002) (181)
Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. (1982) (180)
Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. (1975) (179)
Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry: A Prospective Meta-Analysis From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (2010) (177)
Recovery of Left Ventricular Segmental Function after Long‐Term Reperfusion Following Temporary Coronary Occlusion in Conscious Dogs: Comparison of 2‐ and 4‐Hour Occlusions (1983) (174)
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. (1988) (173)
Inhibition of α4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice (1998) (168)
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure. (2015) (168)
Serum digoxin concentrations in the human fetus, neonate and infant. (1972) (167)
Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. (1979) (166)
A controlled trial of verapamil for Prinzmetal's variant angina. (1981) (165)
Morphologic Correlates of Technetium‐99m Stannous Pyrophosphate Imaging of Acute Myocardial Infarcts in Dogs (1975) (164)
Reduced Myocardial Reflow and Increased Coronary Vascular Resistance following Prolonged Myocardial Ischemia in the Dog (1975) (163)
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. (2001) (163)
Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice (2015) (161)
Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy (2005) (159)
Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. (1984) (157)
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. (2005) (156)
Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. (1997) (155)
Nuclear Plakoglobin Is Essential for Differentiation of Cardiac Progenitor Cells to Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy (2011) (154)
CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. (2011) (153)
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. (1989) (152)
Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. (1981) (150)
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. (1991) (149)
Relationship between β‐Adrenergic Receptor Numbers and Physiological Responses during Experimental Canine Myocardial Ischemia (1982) (148)
Acellular human heart matrix: A critical step toward whole heart grafts. (2015) (147)
Abnormal myocardial fluid retention as an early manifestation of ischemic injury. (1976) (147)
Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy (2009) (145)
Suicidal and Accidental Digoxin Ingestion: Report of Five Cases with Serum Digoxin Level Correlations (1971) (145)
Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. (1975) (144)
Detection of acute right ventricular infarction by right precordial electrocardiography. (1982) (143)
Local effect of serotonin released during coronary angioplasty. (1994) (140)
Adult stem cell therapy in perspective. (2003) (139)
Autonomic dysfunction in women with mitral valve prolapse syndrome. (1979) (137)
Intracellular calcium transients and arrhythmia in isolated heart cells. (1991) (137)
Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs. (1976) (136)
Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. (1988) (135)
Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. (1991) (135)
The use of high-sensitivity assays for C-reactive protein in clinical practice (2008) (135)
Mitogenic effect of serotonin on vascular endothelial cells. (1994) (135)
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. (2002) (134)
Serum myoglobin level as diagnostic test in patients with acute myocardial infarction. (1977) (134)
Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. (1996) (132)
Prospects for cardiovascular research. (2001) (131)
Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. (2002) (131)
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. (2007) (130)
Exercise‐induced Alterations in Left Ventricular Volumes and the Pressure‐Volume Relationship: A Sensitive Indicator of Left Ventricular Dysfunction in Patients with Coronary Artery Disease (1981) (128)
Human Molecular Genetic and Functional Studies Identify TRIM63, Encoding Muscle RING Finger Protein 1, as a Novel Gene for Human Hypertrophic Cardiomyopathy (2012) (126)
Intraaortic balloon counterpulsation in patients in cardiogenic shock, medically refractory left ventricular failure and/or recurrent ventricular tachycardia. (1975) (125)
Ryanodine: its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. (1979) (124)
Combined Therapy With Simvastatin and Bone Marrow–Derived Mesenchymal Stem Cells Increases Benefits in Infarcted Swine Hearts (2009) (124)
Clinicopathologic correlates of acute ischemic heart disease syndromes. (1981) (123)
In vivo measurement of myocardial mass using nuclear magnetic resonance imaging. (1986) (119)
Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. (1985) (119)
Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. (1990) (118)
Thrombolysis in acute myocardial infarction. (1993) (116)
Metabolic syndrome epidemic. (2003) (116)
Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study (2009) (115)
Global position paper on cardiovascular regenerative medicine (2017) (115)
The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. (1984) (114)
Resolution of Established Cardiac Hypertrophy and Fibrosis and Prevention of Systolic Dysfunction in a Transgenic Rabbit Model of Human Cardiomyopathy Through Thiol-Sensitive Mechanisms (2009) (113)
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. (1996) (113)
Inhibition of Cyclic Flow Variations in Stenosed Canine Coronary Arteries by Thromboxane A2/Prostaglandin H2 Receptor Antagonists (1986) (112)
Association of cytomegalovirus infection with the postperfusion syndrome. (1968) (112)
Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. (1997) (111)
Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty A Multicenter Randomized Double‐Blind Placebo‐Controlled Trial (1993) (111)
Measurement of acute myocardial infarcts in dogs with 99mTc-stannous pyrophosphate scintigrams. (1976) (111)
Clinical and Angiographic Predictors of Restenosis After Percutaneous Coronary Intervention: Insights From the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) Trial (2004) (110)
Influence of Dobutamine on Regional Myocardial Blood Flow and Ventricular Performance During Acute and Chronic Myocardial Ischemia in Dogs (1976) (110)
Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. (1988) (109)
Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-&agr;, Interleukin-1&bgr;, and Interferon-&ggr; (2003) (107)
Clinical implications of anterior S-T segment depression in patients with acute inferior myocardial infarction. (1982) (103)
Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. (1985) (102)
Five common gene variants identify elevated genetic risk for coronary heart disease (2007) (102)
Prostaglandins and ischemic heart disease. (1981) (102)
Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure (2004) (100)
Ryanodine-induced stimulation of net Ca++ uptake by cardiac sarcoplasmic reticulum vesicles. (1979) (100)
Origin of the Right Coronary Artery from the Opposite Sinus of Valsalva in Adults: Characterization by Intravascular Ultrasonography at Baseline and After Stent Angioplasty (2015) (99)
Alterations of ultrastructure and elemental composition in cultured neonatal rat cardiac myocytes after metabolic inhibition with iodoacetic acid. (1985) (97)
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. (1989) (97)
Relationship between Epicardial S‐T Segment Changes and Myocardial Metabolism during Acute Coronary Insufficiency (1973) (97)
Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. (1978) (96)
Primary amyloidosis. Clinical, immunochemical and immunoglobulin metabolism. Studies in fifteen patients. (1969) (96)
Cyclooxygenase-2 inhibition and cardiovascular events. (2002) (95)
Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. (1986) (94)
Alterations in left ventricular volumes and ejection fraction at rest and during exercise in patients with aortic regulation. (1981) (91)
Transendocardial Autologous Bone Marrow Mononuclear Cell Injection in Ischemic Heart Failure: Postmortem Anatomicopathologic and Immunohistochemical Findings (2005) (91)
Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. (2012) (91)
Transplantation of Mesenchymal Cells Rejuvenated by the Overexpression of Telomerase and Myocardin Promotes Revascularization and Tissue Repair in a Murine Model of Hindlimb Ischemia (2013) (90)
Inflammatory markers in coronary heart disease. (2011) (90)
The role of periadventitial fat in atherosclerosis. (2007) (88)
Genomic Variation Associated With Mortality Among Adults of European and African Ancestry With Heart Failure: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (2010) (88)
Human CD34+ Cells in Experimental Myocardial Infarction: Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action (2010) (88)
Unstable angina pectoris. Clinical, angiographic, and myocardial scintigraphic observations. (1976) (87)
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease (1978) (87)
Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overload. (1986) (85)
The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction (2017) (85)
Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. (1986) (85)
Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. (1981) (84)
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. (2009) (84)
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina (2001) (83)
The medical treatment of dissecting aortic aneurysms. (1972) (82)
Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. (1984) (82)
Influence of Aging on Left Ventricular Hemodynamics and Stiffness in Beagles (1979) (82)
Finding vulnerable atherosclerotic plaques: is it worth the effort? (2004) (82)
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (The MILIS study) (1987) (82)
Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. (1998) (81)
Gated blood pool imaging following 99mTc stannous pyrophosphate imaging. (1976) (80)
New developments in the detection of vulnerable plaque (2001) (79)
Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. (1985) (79)
Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene. (2016) (78)
Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. (1974) (78)
The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies. (1987) (77)
Value of radionuclide ventriculography in the immediate characterization of patients with acute myocardial infarction. (1982) (77)
Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy. (1979) (77)
Cardioversion and “False Positive” Technetium‐99m Stannous Pyrophosphate Myocardial Scintigrams (1976) (77)
Redistribution of catecholamines in the ischemic zone of the dog heart. (1984) (76)
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. (2004) (76)
Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. (1991) (76)
Intracoronary thermography for detection of high-risk vulnerable plaques. (2006) (76)
Clinicopathologic Study of Persistently Positive Technetium-99m Stannous Pyrophosphate Myocardial Scintigrams and Myocytolytic Degeneration After Myocardial Infarction (1977) (75)
Thermal detection of vulnerable plaque. (2002) (75)
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. (2000) (75)
Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries (2001) (74)
Direct measurement of cardiac output by gated equilibrium blood pool scintigraphy: validation of scintigraphic volume measurements by a nongeometric technique. (1981) (73)
Effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. (1996) (73)
Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. (1993) (72)
Abolition of Cyclic Flow Variations in Stenosed, Endothelium‐Injured Coronary Arteries in Nonhuman Primates With a Peptide Fragment (VCL) Derived From Human Plasma von Willebrand Factor–Glycoprotein Ib Binding Domain (1994) (72)
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. (2000) (72)
Unstable angina pectoris: a randomized study of patients treated medically and surgically. (1978) (72)
Treatment of hind limb ischemia using angiogenic peptide nanofibers. (2016) (72)
The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. (1987) (71)
Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease. (1983) (71)
Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. (1994) (70)
A randomized, controlled study of autologous therapy with bone marrow–derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia (2011) (70)
Editor's commentary: centers of excellence. (2003) (69)
Gadonanotubes as magnetic nanolabels for stem cell detection. (2010) (67)
Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. (1995) (67)
Systemic and local inflammation in patients with unstable atherosclerotic plaques. (2002) (66)
Detection of myoglobin by radioimmunoassay in human sera: Its usefulness and limitations as an emergency room screening test for acute myocardial infarction☆ (1978) (65)
Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial (1993) (65)
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure) (2018) (65)
Lanthanum probe studies of cellular pathophysiology induced by hypoxia in isolated cardiac muscle. (1977) (65)
Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. (1989) (64)
Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. (1970) (63)
Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. (1986) (63)
Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). (2006) (63)
Functional characterization of left ventricular segmental responses during the initial 24 h and 1 wk after experimental canine myocardial infarction. (1979) (62)
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. (2010) (61)
Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. (1988) (61)
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. (1999) (61)
Computed Tomography for Localization and Sizing of Experimental Acute Myocardial Infarcts (1978) (61)
Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? (1998) (60)
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. (2005) (59)
Myocardial infarct imaging with technetium-99m phosphates. (1977) (59)
Influence of Temperature on the Mechanical Properties of Cardiac Muscle (1974) (58)
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy (2019) (57)
Left ventricular function during lower body negative pressure. (1977) (57)
Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion. (1991) (57)
Dual-Energy Computed Tomography Imaging of Atherosclerotic Plaques in a Mouse Model Using a Liposomal-Iodine Nanoparticle Contrast Agent (2013) (57)
Augmented Vasoconstrictor Responses to Serotonin Precede Development of Atherosclerosis in Aorta of WHHL Rabbit (1989) (56)
Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy. (1980) (56)
Imaging Long-Term Fate of Intramyocardially Implanted Mesenchymal Stem Cells in a Porcine Myocardial Infarction Model (2011) (56)
Radioimmunoassay of creatine kinase-B isoenzyme in human sera: results in patients with acute myocardial infarction. (1977) (56)
Analytical electron microscopic study of mitochondrial inclusions in canine myocardial infarcts. (1976) (54)
Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. (1988) (54)
Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). (2010) (54)
Fusion of Human Hematopoietic Progenitor Cells and Murine Cardiomyocytes Is Mediated by &agr;4&bgr;1 Integrin/Vascular Cell Adhesion Molecule-1 Interaction (2007) (54)
99mTc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. (1984) (53)
Prognostic value of submaximal exercise radionuclide ventriculography after myocardial infarction. (1983) (53)
A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial (2021) (53)
Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. (2008) (53)
Prostacyclin therapy for pulmonary arterial hypertension. (2010) (53)
Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. (1983) (52)
Influence of hypertonic mannitol on ventricular performance and coronary blood flow in patients. (1975) (52)
Selective Augmentation of Prostacyclin Production by Combined Prostacyclin Synthase and Cyclooxygenase-1 Gene Transfer (2001) (52)
Infarct sizing with technetium-99m stannous pyrophosphate scintigraphy in dogs and man; relationship between scintigraphic and praecordial mapping estimates of infarct size in patients. (1977) (52)
Differences in myocardial α- and β-adrenergic receptor numbers in different species (1983) (52)
Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular Dysfunction: BM CD34, CD11b, and Clonogenic Capacity as Biomarkers for Clinical Outcomes (2014) (52)
Thermography basket catheter: In vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques (2003) (52)
Differential enhancement of postischemic segmental systolic thickening by diltiazem. (1990) (52)
Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. (1995) (52)
Submaximal exercise testing after acute myocardial infarction: myocardial scintigraphic and electrocardiographic observations. (1978) (51)
Autoradiographic characterization of beta adrenergic receptors in coronary blood vessels and myocytes in normal and ischemic myocardium of the canine heart. (1984) (51)
Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes. (1989) (51)
Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. (1985) (51)
Clinical assessment of external pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial. (1980) (51)
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. (2015) (51)
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature. (2010) (51)
Combination of Inhibition of Thrombin and Blockade of Thromboxane A2 Synthetase and Receptors Enhances Thrombolysis and Delays Reocclusion in Canine Coronary Arteries (1992) (51)
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. (2001) (50)
Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: effects of mannitol, polyethylene glycol, and propranolol. (1981) (50)
Myocardin A Enhances Telomerase Activities in Adipose Tissue Mesenchymal Cells and Embryonic Stem Cells Undergoing Cardiovascular Myogenic Differentiation (2008) (50)
Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits. (1989) (50)
Is anterior ST depression with acute transmural inferior infarction due to posterior infarction? A vectorcardiographic and scintigraphic study. (1984) (50)
Technetium stannous pyrophosphate myocardial scintigrams in the recognition of myocardial infarction in patients undergoing coronary artery revascularization. (1976) (49)
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis (2009) (48)
Perioperative myocardial infarction diagnosed by technetium 99m stannous pyrophosphate myocardial scintigrams. (1976) (48)
Experimental infarct sizing using computer processing and a three-dimensional model. (1977) (48)
Redefining medical treatment in the management of unstable angina. (2011) (48)
Cardiovascular Function during Early Recovery from Acute Myocardial Infarction (1977) (48)
Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies (2018) (47)
Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease. (1980) (47)
E2F-1 Regulates Nuclear Factor-&kgr;B Activity and Cell Adhesion: Potential Antiinflammatory Activity of the Transcription Factor E2F-1 (2002) (46)
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). (2013) (46)
Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. (1981) (46)
Verapamil therapy for Prinzmetal's variant angina: comparison with placebo and nifedipine. (1982) (46)
Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications. (2013) (46)
Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction. (1986) (46)
Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN) (2010) (46)
Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries (2001) (46)
Clinical Implications of the Technetium-99m Stannous Pyrophosphate Myocardial Scintigraphic "Doughnut" Pattern in Patients with Acute Myocardial Infarcts (1979) (45)
Integrin α2β1 Mediates Tyrosine Phosphorylation of Vascular Endothelial Cadherin Induced by Invasive Breast Cancer Cells* (2012) (45)
The neurogenic vasoconstrictor effect of digitalis on coronary vascular resistance. (1974) (45)
Etiology and differential diagnosis of acute mitral regurgitation. (1971) (45)
Molecular Genetic and Functional Characterization Implicate Muscle-Restricted Coiled-Coil Gene (MURC) as a Causal Gene for Familial Dilated Cardiomyopathy (2011) (45)
Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes. (1989) (45)
Nuclear magnetic resonance imaging in Marfan's syndrome. (1987) (44)
Effect of increasing heart rate in patients with aortic regurgitation. Effect of incremental atrial pacing on scintigraphic, hemodynamic and thermodilution measurements. (1982) (44)
Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: preliminary observations in 10 patients. (1981) (44)
Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog. (1982) (44)
Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. (1995) (44)
Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography. (1984) (44)
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. (2011) (43)
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations. (1990) (43)
Coronary artery flow monitoring following coronary interventions. (1993) (43)
January 7/14, 2003 (2003) (42)
Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro. (2016) (42)
Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis. (1994) (42)
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. (2010) (42)
Preoperative statin therapy decreases risk of postoperative renal insufficiency. (2010) (42)
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function Final 2-Year Analysis (2017) (42)
Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formation. (1998) (42)
Temporal Changes in Collateral Coronary Blood Flow in Ischemic Myocardium During Intra‐aortic Balloon Pumping (1974) (42)
Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs. (1989) (42)
Histopathological Study of Healing After Allogenic Mesenchymal Stem Cell Delivery in Myocardial Infarction in Dogs (2009) (42)
Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy. (1983) (41)
High-Risk Cardiovascular Conditions in Sports-Related Sudden Death: Prevalence in 5,169 Schoolchildren Screened via Cardiac Magnetic Resonance. (2018) (41)
Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury. (1991) (41)
A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder (2017) (40)
Effect of glucose availability on functional membrane integrity, ultrastructure and contractile performance following hypoxia and reoxygenation in isolated feline cardiac muscle. (1980) (40)
Influence of acute myocardial depression on left ventricular stiffness and its elastic and viscous components. (1975) (40)
The influence of hypertonic mannitol on regional myocardial blood flow during acute and chronic myocardial ischemia in anesthetized and awake intact dogs. (1975) (40)
Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes. (1982) (39)
Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. (1992) (39)
Determination of left ventricular mass by single-photon emission computed tomography with thallium-201. (1984) (38)
Detection of myocardial infarct extension by CK-B radioimmunoassay. (1979) (38)
Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. (1991) (38)
Reduction of Experimental Myocardial Infarct Size with Hyperosmolar Mannitol (1976) (38)
Measurement of infarct size in acute canine myocardial infarction by single-photon emission computed tomography with technetium-99m pyrophosphate. (1984) (38)
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study (2010) (38)
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. (2010) (37)
Pharmacologic approaches to reperfusion injury. (1997) (37)
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. (2011) (37)
Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty. (1992) (36)
Characterization of a potentially reversible increase in beta-adrenergic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism. (1985) (36)
Hemodynamic evaluation of the Carpentier-Edwards bioprosthesis in the aortic position. (1979) (36)
Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction. (1985) (36)
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). (2017) (36)
Characterization of arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and New Zealand white (NZW) rabbit aortas. (1988) (35)
Influence of volume dilution, lactate, phosphate, and calcium on mitochondrial functions. (1979) (35)
Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. (1990) (35)
Endothelial-Like Progenitor Cells Engineered to Produce Prostacyclin Rescue Monocrotaline-Induced Pulmonary Arterial Hypertension and Provide Right Ventricle Benefits (2013) (35)
Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. (1990) (34)
Early Systolic Clicks due to Mitral Valve Prolapse (1971) (34)
Radionuclide techniques for valvular regurgitant index: comparison in patients with normal and depressed ventricular function. (1982) (34)
Quantitative x-ray microanalysis of the elemental composition of individual myocytes in hypoxic rabbit myocardium. (1983) (34)
Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. (2005) (34)
Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo. (1984) (34)
Comparison of different noninvasive methods of infarct sizing during experimental myocardial infarction. (1977) (33)
Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction (2021) (33)
Influence of calcium on the inotropic actions of hyperosmotic agents, norepinephrine, paired electrical stimulation, and treppe. (1974) (33)
Molecular Imaging of Mesenchymal Stem Cell: Mechanistic Insight Into Cardiac Repair After Experimental Myocardial Infarction (2012) (33)
High-output cardiac failure in patients with multiple myeloma. (1988) (33)
Amyloid coronary artery disease, primary systemic amyloidosis and paraproteinemia. (1970) (32)
Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. Evidence for recovery from near fatal myocardial stunning. (1994) (32)
Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate. (1987) (32)
Marked Thrombosis and Calcification of Porcine Heterograft Valves (1980) (32)
One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction. (2014) (32)
Restenosis after coronary angioplasty. (1993) (32)
Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia (2016) (32)
Verapamil for unstable angina at rest: a short-term randomized, double-blind study. (1983) (32)
Clinical physiology: Skeletal muscle metabolites in patients with cardiogenic shock or severe congestive heart failure (1975) (32)
Myoglobinemia is an Early and Quantitative Index of Acute Myocardial Infarction (1978) (32)
Cardiac resynchronization therapy: helpful now in selected patients with CHF. (2004) (31)
Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease. (1982) (31)
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study (2018) (31)
ACCF/AHA consensus conference report on professionalism and ethics. (2004) (31)
A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride. (1983) (31)
Cause and course of acute myocardial infarction. (1980) (31)
Acute myocardial infarction imaged with 99mTc-stannous pyrophosphate and 201Tl: a clinical evaluation. (1976) (31)
Recent developments in cardiovascular stem cells. (2014) (30)
Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. (1990) (30)
Variant angina pectoris: a clinical and coronary arteriographic spectrum. (1975) (30)
Nongeometric determination of right ventricular volumes from equilibrium blood pool scans. (1982) (30)
Attenuation compensation in single-photon emission tomography: a comparative evaluation. (1982) (29)
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. (2001) (29)
Abnormal myocardial fluid retention as an early manifestation of ischemic injury. (1977) (29)
The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. (2014) (29)
Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial (2016) (29)
Preventing sudden cardiac death in athletes: in search of evidence-based, cost-effective screening. (2013) (29)
The ubiquitin-proteasome system: A potential therapeutic target for heart failure. (2017) (29)
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study. (2002) (29)
Inhibitors of platelet glycoprotein IIb/IIIa receptors. Will they be useful when given chronically? (1996) (28)
Non-invasive assessment of prosthetic mitral paravalvular and intravalvular regurgitation. (1972) (28)
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. (1993) (28)
Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. (2012) (28)
Measurement of myocardial infarction fraction using single photon emission computed tomography. (1985) (28)
Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. (1996) (28)
Differences in myocardial alpha- and beta-adrenergic receptor numbers in different species. (1983) (28)
Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. (1983) (28)
Molecular and Cellular Cardiology (1994) (28)
Alterations in β-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion (1990) (27)
Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion. (1992) (27)
July 2, 2002 Rapid Access Publication (2002) (27)
Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs. (1985) (27)
Magnetic Resonance Imaging-Based Screening Study in a General Population of Adolescents. (2018) (27)
Thallium-201 myocardial perfusion studies in patients with the mitral valve prolapse syndrome. (1978) (27)
Radioimmunoassay of serum creatine kinase B isoenzyme in the diagnosis of acute myocardial infarction. Correlation with technetium-99m stannous pyrophosphate myocardial scintigraphy. (1980) (27)
Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats (1970) (27)
Peripheral Venous Platelet Aggregates in Patients With Unstable Angina Pectoris and Acute Myocardial Infarction (1977) (26)
Basis of pH-independent inhibitory effects of lactate on 45Ca movements and responses to KCl and PGF2 alpha in canine coronary arteries. (1980) (26)
Influence of hyperosmolar agents on hypoxic cat papillary muscle function. (1974) (26)
In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate. (1989) (26)
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? (2009) (26)
Computed tomography: in vitro evaluation of myocardial infarction. (1977) (26)
Egyptian contributions to cardiovascular medicine. (1996) (26)
Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes (2017) (25)
Abstract 17966: First In Man Transendocardial Injection of Autologous AdiPose-deRived StEm Cells in Patients with Non RevaScularizable IschEmic Myocardium (PRECISE) (2010) (25)
Positive 99mTc-stannous pyrophosphate myocardial image in a patient with carcinoma of the lung. (1977) (25)
Dissecting aortic aneurysm involving a right-sided aortic arch. (1979) (24)
Effect of coronary blood flow and site of injection on Tc-99m PPi detection of early canine myocardial infarcts. (1981) (24)
Radionuclide assessment of ventricular function and risk stratification after myocardial infarction. (1991) (24)
Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion* (2013) (24)
Beta-receptor-adenylate cyclase coupling in hypoxic neonatal rat ventricular myocytes. (1989) (24)
Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). (2000) (24)
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). (2010) (24)
Polyarteritis nodosa with bilateral renal artery aneurysms and perirenal haematomas: angiographic and nephrotomographic features. (1970) (23)
Amyloidosis Induced in Mice by Escherichia coli Endotoxin (1968) (23)
Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation (2014) (23)
Effects of Systemic Hypertension on Ischemic and Nonischemic Regional Left Ventricular Function in Awake, Unsedated Dogs After Experimental Coronary Occlusion (1982) (23)
What is wrong with the failing heart? (1982) (22)
Relationship of ischemic heart disease to sudden death. (1991) (22)
TIHROMBOLYSIS Thrombolysis in Myocardial Infarction ( TIMI ) Trial , Phase I : a comparison between intravenous tissue plasminogen activator and intravenous streptokinase (22)
Experimental murine amyloid. IV. Amyloidosis and immunoglobulins. (1969) (22)
NOVEL MRI–BASED SCREENING PROTOCOL TO IDENTIFY ADOLESCENTS AT HIGH RISK OF SUDDEN CARDIAC DEATH (2013) (22)
Determination of left ventricular mass using single-photon emission computed tomography. (1985) (22)
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network. (2012) (22)
Abnormal lanthanum accumulation due to ischemia in isolated myocardium: effect of chlorpromazine. (1981) (22)
Propranolol in acute myocardial infarction: the MILIS experience. (1986) (22)
Quantitation of experimental canine infarct size with multipinhole and rotating-slanthole tomography. (1981) (22)
Technetium-labeled heparin: preliminary report of a new radiopharmaceutical with potential for imaging damaged coronary arteries and myocardium. (1978) (22)
Surfactant-free Gd(3+)-ion-containing carbon nanotube MRI contrast agents for stem cell labeling. (2015) (21)
A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. (1997) (21)
Inhibition of tumor-necrosis-factor-α induced endothelial cell activation by a new class of PPAR-γ agonists : An in vitro study showing receptor-independent effects (2005) (21)
Quantitation of experimental canine infarct size using multipinhole single-photon tomography. (1981) (21)
Negative inotropic influence of hyperosmotic solutions on cardiac muscle. (1975) (21)
Influence of Mannitol on Maintaining Coronary Flows and Salvaging Myocardium during Ventriculotomy and during Prolonged Coronary Artery Ligation (1977) (21)
Diagnosing and Managing Unstable Angina, Quick Reference Guide for Clinicians (1994) (21)
The role of coronary arterial spasm in ischemic heart disease. (1981) (21)
Serotonin and Thrombotic Complications (1991) (21)
A new device for exercise MR imaging. (1986) (21)
Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy. (2001) (21)
Reduction in exertional myoglobinemia after physical conditioning. (1979) (20)
Intra-Arterial Transplantation of Adult Bone Marrow Cells Restores Blood Flow and Regenerates Skeletal Muscle in Ischemic Limbs (2009) (20)
Comparison of the influence of acute transmural and nontransmural myocardial infarction on ventricular function. (1984) (20)
Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction (2011) (20)
Influence of mannitol on contractile responses of isolated perfused arteries. (1977) (20)
Verapamil administration in variant angina pectoris. Efficacy shown by ecg monitoring. (1981) (20)
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1 (2018) (20)
Mycoplasma hyorhinis swine arthritis. II. Morphologic features. (1971) (20)
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients (2020) (19)
Similarities in coronary flow between external counterpulsation and intra-aortic balloon pumping. (1976) (19)
Therapeutic substitution: guilty until proven innocent. (2003) (19)
Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial. (2006) (19)
ST isopotential precordial surface maps in patients with acute myocardial infarction. (1979) (19)
Nuclear magnetic resonance study of high‐energy phosphate stores in models of adriamycin cardiotoxicity (1986) (18)
Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. (2004) (18)
Usefulness of multidetector computed tomography for noninvasive evaluation of coronary arteries in asymptomatic patients. (2006) (18)
Task force 2: Investigator participation in clinical research. (2004) (18)
Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. (2009) (18)
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. (2009) (18)
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial (2018) (18)
Are 99mTc-Stannous Pyrophosphate Myocardial Scintigrams Clinically Useful? (1977) (17)
The editor's roundtable: the JUPITER trial--initial results and clinical implications. (2009) (17)
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial (2000) (17)
Single Nucleotide Polymorphisms Associated with Coronary Heart Disease Predict Incident Ischemic Stroke in the Atherosclerosis Risk in Communities Study (2008) (17)
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size. (1988) (17)
Ischemic heart disease : clinical and pathophysiological aspects (1982) (17)
Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells (2012) (17)
Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas. (2001) (17)
Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes. (1990) (17)
Human CD 34 Cells in Experimental Myocardial Infarction Long-Term Survival , Sustained Functional Improvement , and Mechanism of Action (2010) (17)
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. (2000) (16)
Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. (1990) (16)
Intravascular thermography: a novel approach for detection of vulnerable plaque (2002) (16)
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. (2016) (16)
[Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]. (2008) (16)
Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation (2014) (16)
Pathophysiology of heart failure: a look at the future. (1999) (16)
Increased incidence and clinical correlation of persistently abnormal technetium pyrophosphate myocardial scintigrams following acute myocardial infarction in patients with diabetes mellitus. (1982) (16)
Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial). (2005) (16)
Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes (2004) (16)
Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells. (2013) (16)
Neurological manifestations of pulmonary thromboembolism. (1967) (16)
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials (2015) (15)
A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease. (2011) (15)
Effect of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with Prinzmetal's variant angina pectoris. (1981) (15)
Q-wave versus non-Q-wave myocardial infarction. (1989) (15)
Reducing mortality in patients with extensive myocardial infarction. (1991) (15)
Murine amyloid. II. Transfer of an amyloid-accelerating substance. (1969) (15)
Membrane phospholipid metabolism during myocardial ischaemia: past, present and future. (1987) (15)
Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. III. Influence of basal heart rate. (1984) (15)
CD34+/M-cadherin+ Bone Marrow Progenitor Cells Promote Arteriogenesis in Ischemic Hindlimbs of ApoE−/− Mice (2011) (15)
Role of new antiplatelet agents as adjunctive therapies in thrombolysis. (1991) (15)
A new model for the assessment of regional ventricular wall motion. (1982) (15)
DELAYED FATAL HEMORRHAGE AFTER TRACHEOTOMY. (1965) (15)
The Influence of Combined Intra‐aortic Balloon Counterpulsation and Hyperosmotic Mannitol on Regional Myocardial Blood Flow in Ischemic Myocardium in the Dog (1976) (15)
Experimental murine amyloid. 3. Amyloidosis induced with endotoxins. (1969) (15)
Membrane damage in ischemia. (1983) (14)
Changes in regional coronary blood flow with hypertonic mannitol in conscious dogs. (1975) (14)
Growth Suppression of Human Coronary Vascular Smooth Muscle Cells by Gene Transfer of the Transcription Factor E2F-1 (2001) (14)
Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding. (1994) (14)
Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries. (1983) (14)
CD34+ autologous human stem cells in treating refractory angina. (2011) (14)
Contraction duration and diastolic stiffness in aged canine left ventricle. (1976) (14)
Infarct size--can it be measured or modified in humans? (1987) (14)
Task Force on Strategic Research Direction: Clinical Science Subgroup key science topics report. (2002) (14)
How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance. (2002) (14)
January 1/8, 2002: Expedited Publication of Accepted Manuscripts in Circulation (2002) (14)
Technetium-99m stannous pyrophosphate myocardial scintigrams to recognize acute subendocardial myocardial infarcts in patients☆ (1976) (14)
Relationships between resting tension and mechanical properties of papillary muscle. (1976) (14)
Skeletal muscle metabolites in patients with cardiogenic shock or severe congestive heart failure. (1975) (14)
Inflammatory Protein Levels and Depression Screening After Coronary Stenting Predict Major Adverse Coronary Events (2009) (14)
"Reciprocal" anterior ST depression early in the course of transmural inferior myocardial infarction: an ECG finding of uncertain clinical significance. (1983) (14)
Spatial localization of NMR signal with a passive surface gradient (1988) (13)
C-reactive protein and coronary heart disease. (2004) (13)
Myocardial rupture after myocardial infarction. Detection by multi-gated image-acquisition scintigraphy. (1982) (13)
Abstract of papers to be presented at the twenty-fifth annual scientific session of the American College of Cardiology New Orleans, Louisiana February 23–26, 1976Cardioversion and its potential role in the production of “false positive” technetium-99m stannous pyrophosphate myocardial scintigrams☆ (1976) (13)
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. (1994) (13)
January 6/13, 2004 (2004) (13)
Influence of hypertonic mannitol on regional myocardial blood flow and ventricular performance in awake, intact dogs with prolonged coronary artery occlusion. (1975) (13)
Stent restenosis: can effective antithrombotic therapy be protective? (1997) (13)
Echocardiography after acute myocardial infarction. (1979) (13)
Effect of Hypertonic Mannitol and Isoproterenol on Regional Coronary Flow Following Right Ventriculotomy (1976) (13)
Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications (2006) (13)
Editorial note Myoglobinemia in myocardial infarction (1983) (12)
Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease (1982) (12)
Intraaortic balloon counterpulsation: its influence alone and combined with various pharmacological agents on regional myocardial blood flow during experimental acute coronary occlusion. (1981) (12)
Ambulatory monitoring of left ventricular function. (1988) (12)
Diagnosing and managing unstable angina (1994) (12)
Effect of hypertonic mannitol and intraaortic counterpulsation on regional myocardial blood flow and ventricular performance in dogs during myocardial ischemia. (1976) (12)
June 1, 2004: Notice of Editorial Office Transition (2004) (12)
Local Gene Transduction of Cyclooxygenase-1 Increases Blood Flow in Injured Atherosclerotic Rabbit Arteries (2005) (12)
Synthesis and evaluation of an anti-MLC1 × anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium. (2011) (12)
Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium. (1983) (12)
The influence of isosorbide dinitrate on regional myocardial blood flow during acute coronary occlusion in the dog. (1978) (12)
We must use the knowledge that we have to treat patients with acute coronary syndromes. (2004) (12)
Health Care on Trial: America’s Medical Malpractice Crisis (2004) (11)
Contraction and resting stiffness of isolated cardiac muscle: effects of inotropic agents. (1977) (11)
Relationship of mitochondrial alterations and 99mTc pyrophosphate uptake during myocardial ischemia. (1982) (11)
Species differences in responses to hyperosmolality and D600 in cat and rat heart. (1978) (11)
Modified technetium-99m heparin for the imaging of acute experimental myocardial infarcts. (1980) (11)
Effect of various degrees of systemic arterial hypertension on acute canine myocrdial ischemia. (1981) (11)
Prologue: Detection of Vulnerable Plaque (2006) (11)
Determinants of plasma vitamin D levels in patients with acute coronary syndromes (2011) (11)
The United States cardiovascular care deficit. (2004) (11)
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies (2021) (10)
Coronary Heart Disease Syndromes: Pathophysiology and Clinical Recognition (2015) (10)
Inhibitory effect of hypertonic mannitol on vasoconstrictor and vasodilator responses of isolated coronary arteries. (1978) (10)
Stem cell therapy for cardiovascular diseases: a progressive journey (2015) (10)
Frame isotropic multiresolution analysis for micro CT scans of coronary arteries (2005) (10)
Ventricular septal defect with altitude-dependent pulmonary hypertension. (1971) (10)
Coronary thermography for detection of vulnerable plaques (2007) (10)
Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody. (1997) (10)
Selection of patients for coronary arteriography. (1985) (10)
Effects of calcium loading and impaired energy production on metabolic and ultrastructural features of cell injury in cultured neonatal rat cardiac myocytes. (1990) (10)
Three-dimensional isotropic wavelets for post-acquisitional extraction of latent images of atherosclerotic plaque components from micro-computed tomography of human coronary arteries. (2007) (9)
Future directions in thrombolysis (1999) (9)
Calcium antagonists for acute ischemic heart disease. (1985) (9)
Myoglobinemia in myocardial infarction. (1983) (9)
Radionuclide ventriculography: II. Anatomic and physiologic aspects. (1987) (9)
Effects of digitalis and calcium on papillary muscles in normal and hypoxic states. (1976) (9)
Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular DysfunctionNovelty and Significance (2014) (9)
Effect of mannitol on mitochondrial morphology in hypoxic myocardium. (1973) (9)
Dietary supplementation with n 3 fatty acids may reduce the rate of restenosis after coronary angioplasty (1987) (9)
Cyclic coronary artery flow in dogs after coronary angioplasty (1990) (9)
Conjunctival petechiae after open-heart surgery. (1971) (9)
Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy. (1990) (9)
Vascular progenitor cells in diabetes mellitus: roles of Wnt signaling and negatively charged low-density lipoprotein. (2009) (9)
The Role of Periadventitial Fat in Atherosclerosis An Adipose Subset With Potential Diagnostic and Therapeutic Implications (2007) (9)
Biomarkers of Inflammation as Surrogate Markers in Detection of Vulnerable Plaques and Vulnerable Patients (2007) (9)
The editor's roundtable: the vulnerable plaque. (2008) (9)
Vascular brachytherapy boon or bust? (2003) (9)
Septic arthritis, the unexpected complication. (1969) (9)
Osmotic drug delivery to ischemic hindlimbs and perfusion of vasculature with microfil for micro-computed tomography imaging. (2013) (9)
Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. (2018) (8)
An Essential Guide to Cardiac Cell Therapy (2006) (8)
Clinical research and future improvement in clinical care: the Health Insurance Portability and Accountability Act (HIPAA) and future difficulties but optimism for the way forward. (2003) (8)
Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams. (1981) (8)
Differences in affinity of cardiac beta-adrenergic receptors for [3H]dihydroalprenolol. (1986) (8)
A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI (2018) (8)
Radionuclide evaluation of cardiac trauma. (1980) (8)
CHANGES IN COLLATERAL CORONARY BLOOD FLOW (CCBF) DISTAL TO A CORONARY OCCLUSION DURING INTRA‐AORTIC BALLOON PUMPING (IABP) (1973) (8)
Myocardial reperfusion: Biology, benefits and consequences (2006) (8)
Prevention and Control of Ventricular Arrhythmias (1980) (8)
Homocysteine and coronary heart disease: a review of the current evidence. (1999) (8)
Stem cell and gene therapy for cardiovascular disease (2015) (8)
Gene transfer of COX-1 improves lumen size and blood flow in carotid bypass grafts. (2010) (8)
Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in patients with stable, exertional angina pectoris (1981) (7)
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1). (2010) (7)
Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion. (1990) (7)
SAI-17: First prototype of a 4-french, 180-degree, side-viewing infrared fiberoptic catheter for thermal imaging of atherosclerotic plaque (2001) (7)
Heart Disease in Women (2001) (7)
Acute Subendocardial Myocardial infarction: Its Detection by Tc-99m-Stannous Pyrophosphate Myocardial Scintigraphy (1980) (7)
Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation. (1996) (7)
Chromosome 9 p 21 Single Nucleotide Polymorphisms Are Not Associated With Recurrent Myocardial Infarction in Patients With Established Coronary Artery Disease (2012) (7)
Serum myoglobin, ionized calcium, and parathyroid function during rhabdomyolysis. (1983) (7)
Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis. (1993) (7)
Effects of Inotropic and Chronotropic Stimuli on Acute Myocardial Ischemic Injury. II. Studies with Dopamine and Ouabain in the Barbiturate‐Anesthetized Dog (1983) (7)
Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. (2005) (7)
Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators. (1991) (7)
Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. (1987) (7)
Resistin Promotes (2004) (7)
Evaluation of left ventricular aneurysm after acute myocardial infarction using tomographic radionuclide ventriculography. (1995) (7)
Technetium-99m MIBI as a myocardial perfusion agent. (1990) (7)
Late development of intractable ventricular tachycardia after acute myocardial infarction. (1974) (7)
Inhibition of (cid:97) 4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice (1998) (7)
Coronary artery flow monitoring following coronary interventions. (1995) (7)
The emerging clinical potential of cardiovascular gene therapy. (1999) (6)
Documentation of experimentally induced thrombus formation using intravascular ultrasound. (1991) (6)
A comparison of verapamil and nifedipine in patients with prinzmetal's variant angina pectoris (1981) (6)
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. (2013) (6)
Radioimmunoassay of myoglobin. (1982) (6)
Verapamil in the treatment of prinzmetal's variant angina: A long-term, double-blind, randomized trial (1981) (6)
SAI-15: Coronary thermosensor basket catheter with thermographic imaging software for thermal detection of vulnerable atherosclerotic plaques (2001) (6)
Detection of right ventricular infarction by right precordial electrocardiograms (1982) (6)
The Effects of α2‐Adrenergic and Serotonergic Receptor Antagonists on Cyclic Blood Flow Alterations in Stenosed Canine Coronary Arteries (1984) (6)
Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. (2005) (6)
Dipyridamole thallium scintigrapy and prognois in coronary artery disease (1990) (6)
The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. (2012) (6)
Global position paper on cardiovascular regenerative medicine Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes ( TACTICS ) international group for the comprehensive cardiovascular application of regenerative medicinal products (2017) (6)
The exercise ECG and related physiological data as markers of critical coronary artery lesions. (2009) (6)
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study (2012) (6)
Controlled, Pilot Trial Evaluating the Safety and Effect of Administration of Bone Marrow Mononuclear Cells 2 to 3 Weeks after Acute Myocardial Infarction (2010) (6)
New directions in the use of calcium channel blockers. (1985) (6)
Editor's commentary: One size does not fit all. (2003) (6)
Hemodynamic Evaluation of Rate Augmentation Produced by Atrial Pacing and Isoproterenol in the Early Postoperative Phase of Cardiac Valve Surgery (1971) (6)
Abstract 5090: Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Risk Classification for Coronary Heart Disease and Implications for Lipid-Modifying Therapy in the White Population of the Atherosclerosis Risk in Communities (ARIC) Study (2008) (6)
Circulation's first 50 years: January 1950 to January 2000. (2000) (6)
Technetium-99m stannous pyrophosphate "hot spot" imaging to detect acute myocardial infarcts. (1979) (6)
Chest Pain in a 26‐Year‐Old Woman With a History of Systemic Lupus Erythematosus and Hypertension (1993) (6)
The TACTICS initiative: Time for a Global Alliance on Cardiovascular Regenerative Medicine (2016) (6)
Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging (2019) (5)
Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries. (1997) (5)
Direct Stimulation of Cardiogenesis: A New Paradigm for Treating Heart Disease. (2017) (5)
Tension and electrolyte changes with Na+-K+ pump inhibition in rat papillary muscle. (1989) (5)
Suppressing Hippo signaling in the stem cell niche promotes skeletal muscle regeneration (2021) (5)
Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists. (1991) (5)
The great enemy--infectious disease. (2004) (5)
Atherosclerotic Vulnerable Plaques: Pathophysiology, Detection, and Treatment (2007) (5)
Pathophysiology of "cold spot" and "hot spot" myocardial imaging agents used to detect ischemia or infarction. (1979) (5)
Coronary thrombolysis with a variant of human tissue-type plasminogen activator in a canine preparation: Slightly enhanced thrombolysis and prolonged time to reocclusion (1991) (5)
Epoprostenol (Prostacyclin) in Unstable Angina (1988) (5)
The Medical and Device-Related Treatment of Heart Failure. (2019) (5)
Prognostic assessment after myocardial infarction: Comparison between coronary angiography and submaximal exercise testing with radionuclide ventriculography (1982) (5)
US health care: entitlement or privilege? (2004) (5)
Oxidative phosphorylation in isolated canine myocardial mitochondria. Effects of in vitro volume dilution, lactate, phosphate, and calcium addition, and lactic acidosis. (1980) (5)
Methylprednisolone and regional myocardial blood flow during acute coronary occlusion. (1976) (5)
Targeted Delivery of Carbaprostacyclin to Ischemic Hindlimbs Enhances Adaptive Remodeling of the Microvascular Network (2013) (5)
Left ventricular functional alterations at rest and during submaximal exercise in patients with recent myocardial infarction. (1983) (5)
Inhibition of inotropic effect of hyperosmotic mannitol by lactate in vitro. (1976) (5)
Cardiovascular Drugs Review of Mechanisms and Clinical Applications (1998) (5)
Detection of acute myocardial infarcts by infarct-avid imaging. (1991) (5)
The Vulnerable Atherosclerotic Plaque (2006) (5)
Diagnostic methods in the assessment of the patient with chest pain. (1984) (5)
32. Bell WR, Pitney WR, Goodwin JF. Therapeutic defibrination with refractory chronic stable angina: Angiographic, coronary in the treatment of thrombotic disease. Lancet 1968;1:490- blood flow, and metabolic changes (abstr). Circulation (1997) (5)
Evidence that combined thromboxane A2 and serotonin receptor blockade might prevent coronary artery thrombosis and the conversion from chronic to acute coronary heart disease syndromes. (1990) (5)
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies. (1991) (5)
Application of infrared fiber optic imaging in atherosclerotic plaques (1999) (4)
Pregnancy and the Heart (2007) (4)
Doctors and hospitals: healthcare's Rubik's cube. (2004) (4)
Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe. (1988) (4)
Preserved homograft function 32 years after surgery in a young patient. (2010) (4)
Serial echocardiography in patients with acute myocardial infarction: its value and prognostic significance. (1979) (4)
Altered calcium homeostasis and membrane integrity in myocardial cell injury. (1988) (4)
Use of chronically-implanted ultrasonic crystals in the intact heart of the cat. (1978) (4)
Effects of Hypertonic Mannitol on Contractile Responses and 45Ca Movements in Isolated Canine Arteries (1979) (4)
A Call for CPCs (1995) (4)
Lipoprotein-Associated Phospholipase A 2 as a Novel Risk Marker for Cardiovascular Disease A Systematic Review of the Literature (2010) (4)
Recovery of left ventricular segmental function following temporary coronary occlusion. (1982) (4)
Phospholipid alterations and membrane injury during myocardial ischemia. (1985) (4)
External, noninvasive cardiac assistance and nitrate administration for patients with unstable angina pectoris or acute coronary insufficiency. (1979) (4)
INFARCT SIZING IN AWAKE, UNSEDATED DOGS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTS (1976) (4)
Subacute phenytoin intoxication syndrome. (1978) (4)
Detection of myoglobin by radioimmmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction. (1978) (4)
Raynaud's disease and phenomenon, a medical approach. (1971) (4)
MYOCARDLAL INFARCTION 99 mTc Pyrophosphate imaging in patients with acute myocardial infarction : comparison of planar imaging with single-photon tomography with and without blood pool overlay (4)
Measurement of myocardial blood flow. (1975) (4)
Clinical diagnosis of acute myocardial infarction. (1989) (4)
Plasma Serotonin Concentrations: Validation of a Sampling Technique Using Long Catheters (1987) (4)
Russell Ross, PhD Visionary Basic Scientist in Cardiovascular Medicine (2001) (4)
Effect of EHDP on Calcium Accumulation and Technetium‐99m Pyrophosphate Uptake in Experimental Myocardial Infarction (1981) (4)
RESULTS OF SYSTEMATIC MRI-BASED PRE-PARTICIPATION SCREENING OF SCHOOL CHILDREN: THE SAMPLE SIZE ISSUE (2015) (4)
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction. (1984) (4)
Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarction. (1988) (4)
Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease. (2006) (4)
Exercise stress laboratories in the future. What should their capabilities be? (1981) (4)
Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries. (1988) (4)
Thrombolytic therapy: a state of the art review. (1992) (4)
Sizing acute myocardial infarcts: present limitations and potential approaches. (1977) (4)
Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic Criteria. (2020) (4)
Connective Tissue Diseases and the Heart (2007) (4)
Medical technology development and approval: the future is now. (2004) (4)
Abstract 4409: Phenotypic Plasticity of LMNA Mutations in Cardiovascular System Includes Isolated Cardiac Progeria, Dilated and Hypertrophic Cardiomyopathies, Atrial Fibrillation, Conduction Defects and Degenerative Valvular Diseases (2008) (3)
Aortographic Features Affecting Prognosis (1972) (3)
What is the current role of nuclear cardiology in clinical medicine? (1990) (3)
Past, present and future of nuclear cardiology. (1979) (3)
Nuclear techniques in myocardial disease: 'hot spot' scanning. (1978) (3)
Effects of serotonin and thromboxane A2 on the coronary collateral circulation. (1992) (3)
Influence of experimental myocardial ischemia on beta adrenergic receptors*1 (1979) (3)
Cytokine profile and ST-elevation myocardial infarction. (2012) (3)
Abstract 3502: First in Man Transendocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Cells in Heart Failure Patients (FOCUS-Bright) (2009) (3)
Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection. (1991) (3)
Effects of verapamil and nifedipine on left ventricular function in patients with prinzmetal's variant angina (1981) (3)
Localization of anti-mitochondrial antibody in experimental canine myocardial infarcts. (1980) (3)
A computer-based scintigraphic method for sizing acute inferior myocardial infarcts. (1980) (3)
814-2 Time course of improvement following stem cell injections in humans with heart failure (2004) (3)
Effects of noise on the determination of ejection fraction from left ventricular time-activity curves. (1977) (3)
Jeffrey M. Isner, MD (2002) (3)
Nitrendipine: effects on vascular responses and myocardial binding. (1984) (3)
Training on the use of transendocardial delivery of biologics for cardiac regeneration. (2010) (3)
ROENTGENOGRAM OF THE MONTH. (1965) (3)
History of Atherosclerosis and Vulnerable Plaque Research (2007) (3)
Circulation Editors and Editorial Board. (2018) (3)
Editors' commentary: mechanical circulatory support. (2003) (3)
Serial analysis of right ventricular function after right ventricular infarction (1982) (3)
Coronary artery flow monitoring: the value of intravascular Doppler for detection of complications after interventions. (1995) (3)
Role of edema in the pathogenesis of ischemic injury (1976) (3)
Abnormal autonomic function in patients with mitral valve prolapse syndrome (1978) (3)
Radionuclide ventriculography: I. Technical aspects. (1987) (3)
Repairing the Infarcted Heart with Stem Cells from Umbilical Cord Stroma (2011) (3)
Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty. (1992) (3)
MYOCARDIAL ISCHEMIA Cooperative mediation by serotonin S 2 and thromboxane A 2 / prostaglandin H 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses (2005) (3)
814-1 Transendocardial injection of autologous bone marrow mononuclear cells may enhance myocardial viability around cell injection site (2004) (3)
Inhibition of arachidonic acid release protects myocardial cell viability during ATP depletion (1986) (3)
Influence of frequency of atrial contraction on coronary blood flow and ventricular performance in the conscious dog with myocardial infarction. (1976) (3)
Quantification of Roughness of Calcific Deposits in Computed Tomography Scans of Human Coronary Arteries (2007) (3)
Handbook of Cardiovascular Clinical Trials (1996) (3)
Technetium 99m stannous pyrophosphate myocardial imaging in the diagnosis of acute myocardial infarction in patients (1974) (3)
Membrane Phospholipid Metabolism during Myocardial Ischemia: Mechanisms of Accumulation of Unesterified Arachidonate (1984) (2)
Thermal Stabilization of Vulnerable Plaques (2007) (2)
Rene G. Favaloro, MD (2001) (2)
Recent advances in nuclear cardiology. 1. "Hot-spot" and "cold-spot" myocardial scintigraphy. (1981) (2)
Inflammation, C-Reactive Protein, and Vulnerable Plaques (2007) (2)
Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk (2015) (2)
Myocardial cellular alterations during myocardial ischemia and evolving infarction. (1988) (2)
Correction to: Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation (2017) (2)
Costal cartilage calcification presenting a doughnut appearance on 99mTc-pyrophosphate myocardial imaging. (1979) (2)
Technetium stannous pyrophosphate myocardial scintigraphy for diagnosing and localizing acute myocardial infarcts. (1976) (2)
Experimental Murine Amyloid (1969) (2)
Circulation in 2002 (2002) (2)
In Memoriam: William B. Kannel (1923–2011) (2011) (2)
Circulation: The Next 5 Years (1993) (2)
Acute subendocardial myocardial infarction (1980) (2)
Thrombin inhibition and coronary artery thrombolysis. (1990) (2)
Improvement in symptoms and exercise capacity at eight weeks in a controlled study of autologous bone marrow cell transplant in humans with severe ischemic heart failure (2003) (2)
IMPROVEMENT IN MYOCARDIAL O2 SUPPLY/DEMAND BY INTRA AORTIC BALLOON COUNTERPULSATION AND PROPRANOLOL (1980) (2)
Till truth makes all things plain: human hearts and stem cells. (2014) (2)
Heparin knhances the synergism between platelet TXA2synthase inhibitioh/receptor blockade (ridogrel) and tissue plasminogen activator in lysing canine coronary thrombi (1991) (2)
Review: thrombolytic therapy for patients with acute myocardial infarction (1987) (2)
Iodine-123 Phenylpentadecanoic Acid: Detection of Acute Myocardial Infarction in Anesthetized Dogs (1984) (2)
Effect of coronary blood flow and site of injection on 99mTc-PYP detection of early canine myocardial infarcts (1980) (2)
TCT-823 Results from LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction from the Cardiovascular Cell Therapy Research Network (2013) (2)
Unstable angina pectoris: medical versus surgical treatment. (1980) (2)
Serial in-hospital myocardial scintigraphic alterations of left ventricular ejection fraction in patients with acute myocardial infarcts (1978) (2)
Paradoxical inhibition of vasoconstrictor and vasodilator responses by hypertonic mannitol in isolated arterial smooth muscle. (1979) (2)
864-2 One-year follow-up of transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy (2004) (2)
SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 4Q25 PREDICT IN-HOSPITAL AND LONG TERM DEVELOPMENT OF ATRIAL FIBRILLATION AND SURVIVAL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING (2011) (2)
1100-56 Comparison between intracoronary infusion and direct transendocardial injection of mesenchymal stem cell in a dog acute ischemia model (2004) (2)
Lactate metabolism and acute canine myocardial ischemia. (1973) (2)
A 17‐Year‐Old Woman With a History of Sexually Transmitted Disease and Productive Cough Who Developed Cardiogenic Shock (1993) (2)
Radionuclide assessment and diagnosis of acute myocardial infarction. (1988) (2)
Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency. (1977) (2)
Diseases of the Aorta (2007) (2)
Texas Heart Institute medal and the Ray C. Fish award for scientific achievement in cardiovascular diseases. (2013) (2)
July 16, 2002 Rapid Access Publication (2002) (2)
New Techniques for the Elemental Analysis of the Myocardium: Application to the Study of Ischemia a (1984) (2)
Fatty acyl metabolites and membrane injury in ischemic canine myocardium: Dissociation from a sarcolemmal Ca++ permeability defect and correlation with mitochondrial dysfunction (1981) (2)
Impact of nuclear cardiac imaging on the present and future practice of cardiology (2000) (2)
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the CHARGE Consortium Running title: Morrison et al; Genomic variation and mortality in adults with HF (2009) (2)
Technetium-99m stannous pyrophosphate myocardial scintigraphy in the recognition of acute subendocardial myocardial infarction. (1977) (2)
Treating relentlessly progressive congestive heart failure: what next? (1998) (2)
Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction. (1990) (2)
Inhibition of Tumor-Necrosis-Factor-αDELETEInduced Endothelial Cell Activation by a New Class of PPAR-γ Agonists (2005) (2)
Computer processing of 99mTc-phosphate myocardial scintigrams (1976) (2)
The combined influence of hypertonic mannitol and intraaortic balloon pumping on collateral coronary blood flow in ischemic myocardium (1974) (2)
Influence of blood sampling site and technique on thromboxane and prostacyclin levels in patients with coronary artery disease (1982) (2)
Myocardial imaging with I-123 phenylpentadecanoic acid in normal volunteers (1985) (2)
Heparin and bone marrow-derived cell therapy: friend or foe? (2012) (2)
Role of Membrane Dysfunction and Altered Calcium Homeostasis in the Pathogenesis of Irreversible Myocardial Injury (1989) (2)
Metabolism of arachidonic acid in 1 yr old New Zealand white (NZW) and watanabe heritable hyperlipidemic (WHHL) rabbit aortas (1986) (2)
Altered expression of multiple genes in the aorta of apolipoprotein-E deficient mice with atherosclerosis: Determination by hybridization of arrayed cDNA clones (2000) (2)
The clinical role of positron emission tomography for cardiology in the 1990s and beyond. (1991) (2)
James B. Herrick Memorial Lecture. (1994) (1)
Edgar Haber, Md: Innovative Scientist, Mentor, and Leader in Cardiovascular Medicine (1998) (1)
Overview and research opportunities (1992) (1)
April 9, 2002 Rapid Access Publication (2002) (1)
Nongeometric Determination of Right Ventricular Equilibrium Blood Pool Scans Volumes From (1982) (1)
Abstract 20201: Fibro-Adipocyte Progenitors are a Cell Source of Adipocytes in Arrhythmogenic Cardiomyopathy (2014) (1)
Investigation of the mechanism of the inotropic effect of hypertonic mannitol in isolated cardiac muscle and of Mannitol's influence on regional myocardial blood flow in dogs with myocardial ischemia (1974) (1)
PATHOPHYSIOLOGY OF- MYOCARDIAL INFARCT SCINTIGRAPHY WITH TECHNETIUM-99m PYROPHOSPHATE, TECHNETIUM-99m DIPHOSPHONATE AND THALLIUH-201 (1976) (1)
An Evaluation Of The Effect Of Gating On 99mtc-pyp Myocardial Scinti-grams (1980) (1)
Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial (2004) (1)
Transplanted bone marrow mesenchymal stem cell distribution pattern in the heart: comparison of delivery routes (2007) (1)
Acute Myocardial Infarct Imaging with 99mTc Stannous Pyrophosphate (1977) (1)
CO-ACTIVATION OF NUCLEAR FACTOR-KB AND MYOCARDIN/SERUM RESPONSE FACTOR IN CANINE CARDIAC MYOBLASTS EXPOSED TO HIGH LEVELS OF INSULIN (2011) (1)
I-123 phenylpentadecanoic acid myocardial imaging at rest and exercise in man: A new noninvasive means to detect ischemic heart disease (1985) (1)
Book ReviewCardiac Emergency Care (1980) (1)
Medical Treatment of Unstable Angina and Acute Non-ST-Elevation Myocardial Infarction (2015) (1)
Platelet, endothelium and smooth muscle cell-derived mediators contributing to the development of unstable angina and myocardial infarction (1995) (1)
Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. (1995) (1)
Importance of calcium in the inotropic effect of hyperosomotic agents, norepinephrine, paired electrical stimulation, and treppe. (1975) (1)
Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques. (2012) (1)
Relationship between myocardial metabolism and epicardial ST segment alterations during myocardial ischemia. (1975) (1)
Special article: Editor's Farewell (2004) (1)
Intramyocardial delivery of bone marrow-derived mesenchymal stem cells improves myocardial contractility in a chronic ischemic model (2003) (1)
Diagnosis and management of angina pectoris. (1976) (1)
Unstable Coronary Syndromes (2005) (1)
CD133+ Stem Cells in the Treatment of Patients With Refractory Angina. (2017) (1)
Platelets, Platelet Mediators, and Unstable Coronary Artery Disease Syndromes (1993) (1)
Techniques for sizing myocardial infarction. (1981) (1)
Recent advances in nuclear cardiology. 2. Dynamic myocardial scintigraphy. (1981) (1)
Technetium-99m-Pyrophosphate Myocardial Imaging (1980) (1)
Detection ofMyocardial Infarct Extension byCK-BRadioimmunoassay (1979) (1)
Adenovirus-mediated gene transfer of recombinant tissue factor pathway inhibitor in vitro and in vivo (1998) (1)
Application of IR and NIR fiber optic imaging in thermographic and spectroscopic diagnosis of atherosclerotic vulnerable plaques: preliminary experience (2000) (1)
Herbert L. Fred, MD, MACP, Appointed Associate Editor of the Texas Heart Institute Journal (2011) (1)
Endocrine Disorders and the Heart (2007) (1)
Abstract 15644: The NHLBI and Cardiovascular Cell Therapy Research Network (CCTRN) TIME Trial: Two-Year Results (2014) (1)
January 29, 2002 Rapid Access Publication (2002) (1)
Changing of the guard? (2015) (1)
Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial (2009) (1)
Entitlement or Privilege (2004) (1)
Herz- und Kreislaufdiagnostik — Diagnosis of Heart and Circulation (1985) (1)
Mechanical Circulatory Support (2003) (1)
Medical Treatment of Stable Angina (2015) (1)
Regional alteration in cardiac adrenergic function in infarcted and non-infarcted myocardium: Noninvasive assessment using I-123 metaiodobenzylguanidine (1990) (1)
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial (2021) (1)
INFLUENCE OF MANNITOL ON SALVAGING MYOCARDIUM DURING VENTRICULOTOMY (1977) (1)
Atherosclerotic Plaques in ApoE-Deficient Mice Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to 4 α Inhibition of Print (1998) (1)
Renal displacement visualized on myocardial scintigram: case report. (1977) (1)
Lipid coated SPIO; introducing a novel tracer for MR imaging of macrophage infiltration in vulnerable atheroaclerotic plaque (2002) (1)
Abstract 3821: Isotropic Wavelet Analysis for Identification of Coronary Atherosclerotic Plaque Components from Computed Tomography (2006) (1)
Improvement in global and segmental left ventricular contractility following autologous bone marrow cell transplantation in humans with severe ischemic heart failure (2003) (1)
What's wrong with the failing heart? (1983) (1)
Mesnenchymal stem cells favor healing and remodeling in a canine acute ischemia model (2007) (1)
Abstract 20536: Desmoplakin Deficient Epicardial Progenitor Cells Mediate the Development of Fibroadiposis in Arrhythmogenic Cardiomyopathy (2017) (1)
Dual Imaging in Acute Myocardial Infarction (1980) (1)
A novel liposomal encapsulated lohexol (Omnipaque) for detection of inflammation by computed tomography: A potential method for identification of vulnerable plaques (2003) (1)
Radionuclide ventriculography: usefulness in evaluating alterations in ventricular function. (1984) (1)
Effects of nifedipine and verapamil during acute myocardial infarction (1982) (1)
July 8, 2003 (2003) (1)
Determination of left ventricular mass in man using single photon emission computed tomography (1984) (1)
Should all patients with risk factors for ischemic heart disease receive aspirin? (1992) (1)
In Memoriam: Geoffrey O. Hartzler (1946–2012) (2012) (1)
Pathological assessment of stem cell therapy for myocardial ischemic disease (2007) (1)
The influence of hypertonic mannitol on hemodynamics and coronary blood flow in patients (1973) (1)
Proceedings: Influence of hypertonic mannitol on regional myocardial blood flow during and in the absence of acute myocardial ischaemia in the conscious intact dog. (1974) (1)
Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest and the New Policy for Involving Schoolchildren. (2015) (1)
Treatment of heart diseases (1992) (1)
Influence ofDobutamine on Regional Myocardial BloodFlowandVentricular Performance During AcuteandChronic Myocardial Ischemia inDogs (1976) (1)
Abstract 14080: A Phase II Randomized, Double-blind, Controlled Trial of Combined Mesenchymal Stromal Cells and C-kit+ Cardiac Progenitor Cells in Ischemic Heart Failure: The CCTRN CONCERT-HF Trial (2020) (1)
Education of an Editor Fulfillment of Promises (1995) (1)
Influence of mannitol on isolated coronary and peripheral arterial smooth muscle (1978) (1)
SINGLE NUCLEOTIDE POLYMORPHISMS IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) GENE ARE NOT ASSOCIATED WITH RECURRENT CARDIOVASCULAR EVENTS OR MORTALITY IN PATIENTS WITH ESTABLISHED ATHEROSCLEROSIS: A MENDELIAN RANDOMIZATION EXPERIMENT (2013) (1)
Influence of hypertonic mannitol on regional myocardial blood flow and in protecting ischemic myocardium during experimental coronary occlusion (1977) (1)
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. (1995) (1)
A clinical trial of intravenous mesenchymal stem cells for treatment of anthracycline associated cardiomyopathy (2019) (1)
Comment Effects of Serotonin and Thromboxane A 2 on the Coronary Collateral Circulation * (1)
Influence of hypertonic mannitol on regional myocardial blood flow during myocardial ischemia in awake, unsedated, and in anesthetized dogs (1974) (1)
Abstract 4934: CLI-Bright: A Phase I Randomized Blinded Clinical Trial Comparing the Effect of Intramuscular Injection of Autologous Bone Marrow Derived Aldehyde Dehydrogenase Bright Cells and Mononuclear Stem Cells in Patients With Critical Limb Ischemia (2009) (1)
Circulation: new opportunities. When all is considered, what matters most is opportunity. (1998) (1)
’ s Roundtable : Advances in Stem Cell Therapy for Treatment of Cardiovascular Disease (2012) (1)
In Memoriam: Herbert L. Fred, MD (1929–2018) (2019) (1)
Coronary artery disease (2012) (1)
Current status of percutaneous coronary intervention: Results from a large international trial (2003) (1)
Comprar Stilbenes: Applications in Chemistry, Life Sciences and Materials Science | Renu Virmani | 9783527323883 | Wiley (2009) (1)
Postoperative Renal Insufficiency among Patients Undergoing Cardiac Surgery (2009) (1)
Early diagnosis of recanalization: the need to know (1992) (1)
Abstract 19643: Transplantation of Bone Marrow Stem Cells Complexed With Immunoliposomes Targeted to Cd34 and Icam-1 Reduces Atherosclerosis in Apolipoprotein-e Null Mice (2010) (1)
Further characterization of the inotropic effect of hypertonic mannitol, paired pacing and treppe in isolated cardiac muscle (1974) (0)
Point of View Research on Unstable Coronary Syndromes Specific Platelet Mediators and Unstable Coronary Artery Lesions Experimental Evidence and Potential Clinical Implications (2005) (0)
Increased incidence of “persistently positive” technetium pyrophosphate myocardial scintigrams following myocardial infarction in diabetics (1982) (0)
Comparative Value and Limitations of Thallium-201 and Technetium-99m-Pyrophosphate Myocardial Imaging in Acute Myocardial Infarction (1980) (0)
1011-108 Cardiac responses to intracoronary-delivered stem cells in apolipoprotein-null mice: Assessment by langendorff perfusion (2004) (0)
New Sections in Circulation (2001) (0)
Technetium-99m-Pyrophosphate Myocardial Imaging in Acute Myocardial Infarction (1980) (0)
Measurement of Myocardial Infarct Size Using Nuclear Cardiology Methods (1984) (0)
In Memoriam: Burton E. Sobel A Tribute from Family, Friends and Colleagues October 21, 1937 – May 3, 2013 (2013) (0)
Preventing sudden cardiac death in athletes (2013) (0)
The Future Is Now (2004) (0)
In Memoriam: Kenneth L. Baughman. (2010) (0)
September 3, 2002 Circulation’s Newest Section Mini-Reviews: Expert Opinions (2002) (0)
November 4, 2003 (2003) (0)
Prevention Of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow-Derived Endothelial-Like Progenitor Cells Expressing An Engineered Protein With Combined Cyclooxygenase-1 And Prostacyclin Synthase Activities (2011) (0)
Effect of Hypertonic Mannitol and Isoproterenol (2005) (0)
Iterative estimation for valvular regurgitant fraction measurements by radionuclide angiocardiography (1978) (0)
P2554Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes revascularization and tissue repair in a murine model of myocardial infarction (2017) (0)
1068-127 Ischemic precondition improves performance of the hearts with coronary delivery of embryonic stem cells: Assessment by a langendorff perfusion model (2004) (0)
Sustained Clinical Improvement after Autologous Bone Marrow Mononuclear Cell Transplantation (ABMMC) in Humans with Severe Ischemic Heart Failure – Four Years Follow up (2006) (0)
Denton Arthur Cooley, MD. (2017) (0)
January 21, 2003 Circulation’s Newest Section Mini-Reviews: Expert Opinions (2003) (0)
Cellular Implantation Therapy (2009) (0)
CIRCULATION : WHERE NOW? (1997) (0)
The Texas Heart Institute: Part 2-Working Toward the Next Breakthrough in Cardiovascular Medicine. (2017) (0)
October 1, 2002 (2002) (0)
Special Case Report Issue: Some Bathtub Reading (2012) (0)
Editor’s Commentary (2003) (0)
March 19, 2002: Rapid Access Publication (2002) (0)
New Developments in Treatment of Vulnerable Plaques (2007) (0)
March 4, 2003: Circulation’s Newest Section Mini-Reviews: Expert Opinions (2003) (0)
Ionic subcellular alterations during hypoxia and reoxygenation in isolated neonatal rat ventricular myocytes (1989) (0)
751-2 Combined Treatment with 3 Antiplatelet Agents Reduces Neointimal Proliferation In Canine Coronary Arteries After Angioplasty (1995) (0)
Alterations of catecholamines and adrenergic receptors in evolving myocardial infarction (1984) (0)
Alterations of cardiac muscle inotropic responsiveness by ryanodine (1978) (0)
CORONARY ARTERY DISEASE Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries (0)
Significance of Tc-99m MIBI lung uptake in patients with known or suspected coronary artery disease undergoing exercise SPECT myocardial perfusion imaging (1995) (0)
arteries Serotonin as a mediator of cyclic flow variations in stenosed canine coronary (2011) (0)
The Next Big Step for the Texas Heart Institute Journal (2013) (0)
Texas Heart Institute Medal and the Ray C. Fish Award for Scientific Achievement in Cardiovascular Diseases. (2016) (0)
Room H, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Educating Medical Students on Pain Management, End of Life Care, and Palliative Care A-1202 (2000) (0)
Unstable Coronary Syndromes Specific Platelet Mediators and Unstable Coronary Artery Lesions Experimental Evidence and Potential Clinical Implications (2005) (0)
Abstract 18363: Activation of the Hippo Pathway, Associated With Suppression the Canonical Wnt Signaling, Contributes to the Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy (2013) (0)
The Role Of Technetium-99m STannous Pyrophosphate In Myocardial Imaging To Recognize, Localize And Identify Extension Of Acute Myocardial Infarction In Patients (1976) (0)
Abstract 12253: Disruption of Endothelial Adherens Junction by High Glucose Concentration is Mediated by HRas/PKC-β-Dependent VE-cadherin Tyrosine Phosphorylation (2012) (0)
March 5, 2002 Rapid Access Publication (2002) (0)
In Memoriam: J. Willis Hurst (1920–2011) (2011) (0)
Cardiac depression during hypoxia: lack of protective effect of hydrocortisone in the perfused rat heart (1973) (0)
In Memoriam: Ketty Schwartz 1937–2007. (2008) (0)
Abstract 15574: Adipose Tissue-Derived Mesenchymal Stem Cells with Myocardin-A and Telomerase Co-Expression Possess Augmented Capacity of Proliferation and Promyogenic Activities (2011) (0)
MURC Variants in Cardiomyopathy (2011) (0)
Effect of mannitol on regional right ventricular coronary flow following right ventriculotomy (1975) (0)
The History and Physical Examination (2007) (0)
Purposes and functions of a department of community medicine. (1972) (0)
June 3, 2003 (2003) (0)
Treatment of Acute ST-Elevation Myocardial Infarction (2015) (0)
Abstract 9178: Cell-Based Prostacyclin Gene Therapy Prevents Pulmonary Arterial Hypertension (2011) (0)
Effects of hyperosomotic mannitol in reducing ischemic swelling and minimizing myocardial necrosis. Discussion. (1976) (0)
April 23, 2002 Rapid Access Publication (2002) (0)
ValvularRegurgitantIndex:Comparisonin Patients withNormalandDepressedVentricularFunction (2006) (0)
Michael E. Debakey, M.D. (2010) (0)
December 17/24, 2002 (2002) (0)
July 1, 2003 (2003) (0)
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor- (cid:1) , in Patients With Moderate-to-Severe Heart Failure Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial Clinical Investigation and Rep (2003) (0)
Abstracts of the current literature (1920) (0)
April 27, 2004 Notice of Editorial Office Transition (2004) (0)
March 2, 2004 (2004) (0)
Abstract 18215: Prostacyclin Secretion From Stably Engineered Rat CD45-VEGFR2+ Endothelial Progenitor Cells Preserves Potassium Channel Activity Of Human Smooth Muscle Cells Under Hypoxia (2010) (0)
February 3, 2004 (2004) (0)
Images in Cardiovascular Medicine Bilateral Carotid Body Tumor Evaluated by Three-Dimensional Multislice Computed Tomography Angiography (2004) (0)
Adult stem cells: Early clinical trials and perspective (2008) (0)
In Memoriam: William Ganz 1919–2009 (2010) (0)
Noninvasive evaluation of left ventricular function by echocardiography during lower body negative pressure (LBNP) (1974) (0)
Acute and Chronic Myocardial Ischemia in Dogs (2005) (0)
Passing of the editorship to Dr. James Willerson. (2008) (0)
July 17, 2001 Rapid Review (2001) (0)
Ischemia induced arachidonate release in the isolated heart (1984) (0)
In memoriam: Ali Massumi, MD (1945-2015). (2015) (0)
Abstract 16663: Patient and Cell Characteristics Associated With Clinical Outcomes in the CCTRN LateTIME Trial (2014) (0)
Scintigraphic evaluation of left ventricular function. (1979) (0)
Mechanical circulatory assistance with intra-aortic balloon. (1973) (0)
In Memoriam: Burton E. Sobel (1937–2013). (2013) (0)
Reduction of cyclic flow variations by endothelin B receptor stimulation is mediated by nitric oxide in rat mesenteric artery model (1996) (0)
Cardiology 1998 (2004) (0)
Species comparison of myocardial inotropic responses to ryanodine (1979) (0)
Preliminary findings using in vivo imaging with radiolabeled monoclonal antibody to ICAM-1 and MHC class II antigen in cardiac allograft rejection (1995) (0)
Technetium-99m-Pyrophosphate Myocardial Imaging in Patients with Atypical Chest Pain (1980) (0)
June 11, 2002 Rapid Access Publication (2002) (0)
Restenosis is not increased in mild or moderate chronic kidney disease: Results from the PRESTO trial (2003) (0)
Basis of ph-independent inhibitory effects of lactate on 45Ca movements and responses to KCl and prostaglandin F2α in canine coronary arteries (1980) (0)
Fusion of Human Hematopoietic Progenitor Cells and Murine Cardiomyocytes Is Mediated by (cid:1) 4 (cid:2) 1 Integrin/Vascular Cell Adhesion Molecule-1 Interaction (2007) (0)
April 2, 2002 Rapid Access Publication (2002) (0)
Combined TXA2 synthase inhibitor/PGH1 receptor antagonism (ridogrel) needs heparin but reduces the RT-PA requirement for effective coronary thrombolysis (1992) (0)
Tanks to the Reviewers (2005) (0)
Abstracts of the current literature (1957) (0)
Congratulations to THI's Professional Staff and Employees. (2009) (0)
Thyrotropin releasing hormone (TRH) uptake in hypothalamic synaptosomes in vitro (1976) (0)
Inflammation Injury and Selected Disease Processes Causing Aortic Root and Aortic Valvular Inflammation (2019) (0)
Cardiovascular News Images in Cardiovascular Medicine Syncope and Supraventricular Tachycardia (2001) (0)
In Memoriam: Donald S. Baim (2010) (0)
Thromboxane A2 and Serotonin are Possible Mediators (2005) (0)
Focus on ECGs: A New Feature of the Texas Heart Institute Journal. (2016) (0)
History of Systemic Lupus Erythematosus and Hypertension (2005) (0)
May 6, 2003 (2003) (0)
March 9, 2004 (2004) (0)
Effects of hypoxia and digitalis glycosides on myocardial stiffness. (1976) (0)
Of Mice and Men . . . and Broken Hearts (2001) (0)
Magnetic Resonance Imaging After Percutaneous Closure of a Patent Foramen Ovale (2001) (0)
Fare Thee Well, Dr. Cooley. (2017) (0)
The Texas Heart Institute: Part 1-An Historical Perspective. (2017) (0)
Stable angina pectoris: recent advances in predicting prognosis and treatment. (1998) (0)
Abstract 18243: Transplantation of Mesenchymal Cells Rejuvenated by Delivery of Telomerase and Myocardin Genes Promotes Revascularization and Tissue Repair in Ischemic Hindlimbs of Apolipoprotein-e-null Mice (2012) (0)
Book ReviewHeart Disease: A textbook of cardiovascular medicine (1981) (0)
August 13, 2002: Circulation’s Newest Section: Expert Opinions (2002) (0)
Abstract 15640: A Digenic Etiology Implicates Alpk3 and Myl2 Variants as Likely Causal Mutations in Familial Hypertrophic Cardiomyopathy (2016) (0)
In Memoriam: Robert A. O'Rourke (1936?2011). (2011) (0)
Procede d'attenuation de la proliferation neointimale (1992) (0)
Understanding Translational Cardiac Stem Cell Research (2006) (0)
Ten years of images from Circulation, journal of the American Heart Assocication (2007) (0)
Catecholamines and adrenergic mechanisms: do they mediate certain consequences of ischemic heart disease? (1982) (0)
Comment Technetium-99 m Pyrophosphate And Indium-Ill Antimyosin Antibody Scintigraphy Appear to Be Comparable Methods for Infarct Detection * (2016) (0)
In Memoriam: Arnold M. Katz, MD (1932–2016) (2016) (0)
May 4, 2004 Notice of Editorial Office Transition (2004) (0)
Doctors and hospitals. (2004) (0)
April 8, 2003 (2003) (0)
In Memoriam: August M. Watanabe. (2010) (0)
Cardiogenic shock and its current treatment. (1975) (0)
October 8, 2002 (2002) (0)
Reperfusion Adjunctive Therapy: Platelet Active Agents (1990) (0)
Unstable angina pectoris Clinical , angiographic , and myocardial scintigraphic observations 1 (0)
October 7, 2003 (2003) (0)
Technetium-99m heparin; a new radiopharmaceutical to identify damaged coronary arteries and damaged myocardium (1978) (0)
Abstract 914: Myozenin 2 (MYOZ2) Is a Novel Gene For Human Hypertrophic Cardiomyopathy (2006) (0)
August 5, 2003 (2003) (0)
Assessment of vasodilator therapy with gated blood pool imaging: Limitations of the ejection fraction (1982) (0)
Human CD34 (cid:1) Cells in Experimental Myocardial Infarction Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action (2010) (0)
Subject Index Vol. 42, 2005 (2005) (0)
In memoriam: Joseph K. Perloff (1924–2014). (2015) (0)
Abstract 17399: Nuclear Plakoglobin Mediates Differentiation of Cardiac Progenitor Cells to Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy (2011) (0)
How to search for the precipitating role of vasoconstriction and its prevalence in myocardial infarction. (2002) (0)
Contents Vol. 42, 2005 (2005) (0)
841-2 Periadventitial fat inflammation correlates with plaque inflammation in patients with coronary plaque ruptures: New marker of plaque vulnerability? (2004) (0)
Clinical and angiographic predictors of cardiac events in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention in the current era: Insights from the PRESTO trial (2003) (0)
Abstract 19830: Reduced Electromechanical Activity Related to the Functional Modification of Ion Channels in Hibernating Myocardium of Porcine Heart (2010) (0)
September 9, 2003 (2003) (0)
Macrophage homing to atherosclerotic plaques in apo-E deficient mice is inhibited by anti-ICAM-1, but not by anti-E-selectin MAb (1998) (0)
Overview of Antiplatelet Therapy (2002) (0)
Radionuclide Techniques forValvular Regurgitant Index:Comparison inPatients withNormal andDepressed Ventricular Function (1982) (0)
Speculation regarding mechanisms responsible for the conversion from chronic to acute ischemic heart disease (1987) (0)
Endothelium-Injured Canine Coronary Arteries (2005) (0)
A comparison of the results of single photon emission tomographic acquisition with circular, elliptical, and contoured orbits (1985) (0)
Computer-assisted computation of infarct size in experimental animals using /sup 99m/technetium phosphate scintigrams (1975) (0)
Endothelial-Like Progenitor Cell-Based Prostacyclin Gene Therapy Provides Survival Benefit To Rats With Established Pulmonary Arterial Hypertension (2012) (0)
Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo Enhancement by Tissue Necrosis Factor- (cid:1) , Interleukin-1 (cid:2) , and Interferon- (cid:3) (2003) (0)
December 18/25, 2001 (2001) (0)
Technetium-99m-Pyrophosphate Myocardial Imaging in Unstable Angina (1980) (0)
April 16, 2002: Rapid Access Publication (2002) (0)
Long-term outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (2003) (0)
MURC ENCODING MUSCLE-RESTRICTED COILED-COIL IS A NOVEL GENE FOR HUMAN DILATED CARDIOMYOPATHY (2010) (0)
Abstract 293: Functional Recovery After Gene Therapy and Hippo Pathway Knock Down After Myocardial Infarction in a Pig Model (2020) (0)
In-silico Prediction of Bioprosthetic Heart Valve Function with In-vivo Operation (2018) (0)
America's Medical Malpractice Crisis (2004) (0)
Relationship between calcium accumulation and uptake of technetium-99m phosphorus radiopharmaceuticals in myocardial infarcts (1977) (0)
Implications of the Technetium-99 m Stannous Pyrophosphate Myocardial Scintigraphic " Doughnut " Pattern in Patients with Acute Myocardial Infarcts (2005) (0)
In Memoriam: Judah Folkman 1933–2008. (2008) (0)
September 17, 2002 Circulation’s Newest Section (2002) (0)
MINIMALLY INVASIVE PERICARDIAL ACCESS DEVICE: PRECLINICAL STUDIES (1997) (0)
May 14, 2002 Rapid Access Publication (2002) (0)
Improvement of quality of life in patients with severe heart failure submitted to myocardial transplantation of autologous bone marrow mononuclear cells (2003) (0)
“Doughnut” Technetium Pyrophosphate Myocardial Scintigrams: A Marker of Severe Left Ventricular Dysfunction (1982) (0)
James Thornton Willerson, MD: a conversation with the editor. Interview by William Clifford Roberts. (1997) (0)
June 4, 2002 Rapid Access Publication (2002) (0)
Adventitial and Periadventitial Fat Inflammation and Plaque Vulnerability (2007) (0)
April 30, 2002 Rapid Access Publication (2002) (0)
Inhibitors of von Willebrand Factor Binding to Platelet Glycoprotein Ib (2002) (0)
Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes activation of the cardiomyogenic program and vasculogenesis, and preserves cardiac function in a murine model of myocardial infarction (2015) (0)
Myocardial Arachidonate Metabolism during ATP Depletion (1985) (0)
SAI-18: MRI detection of atherosclerotic vulnerable plaque using superparamagnetic iron oxide contrast media (2001) (0)
Clinical Cardiology: Physician Update and The Cardiology Patient Page (2001) (0)
Mechanisms of Technetium-99m-Pyrophosphate Accumulation in Damaged Myocardium (1980) (0)
IMMUNOSCINTIGRAPHIC DIAGNOSIS OF CARDIAC ALLOGRAFT REJECTION USING IN VIVO IMAGING WITH RADIOLABELED MONOCLONAL ANTIBODIES TO MHC CLASS II ANTIGENS AND TO INTERCELLULAR ADHESIVE MOLECULE ICAM-I (1996) (0)
Rapid Track for Review and Publication (2001) (0)
Radionuclide imaging of myocardial ischemia and infarction. Discussion. (1976) (0)
NON-COMPACTION LEFT VENTRICLE: NOVEL RESULTS OF SUBTLE MRI SUB-ANALYSIS (2019) (0)
December 3, 2002: Circulation’s Newest Section (2002) (0)
AttenuationCompensationin Single-PhotonEmissionTomography: A ComparativeEvaluation (2006) (0)
Cardiovascular News Images in Cardiovascular Medicine Left Ventricular Pseudoaneurysm Clinical Role of Cardiovascular Magnetic Resonance Imaging (2004) (0)
In Memoriam: Bud Friesinger (1929?2012). (2012) (0)
Medical Treatment of Unstable Angina, Acute Non-ST-Elevation Myocardial Infarction, and Coronary Artery Spasm (2007) (0)
Abstract 3400: Cardiac-Restricted Deletion Of Desmoplakin In Mice Recapitulates The Phenotype of Human Arrhythmogenic Right Ventricular Cardiomyopathy (2006) (0)
Highly Selective Endothelin-A Receptor Antagonist TBC-3711 Prevents Pulmonary Hypertension And Protects Against Hepatic Dysfunction In Monocrotaline Treated Fisher-344 Rats (2011) (0)
The influence of external counterpulsation on collateral coronary blood flow in ischemic myocardium (1974) (0)
Platelets in Thrombotic and Non-thrombotic Disorders: Cardiovascular gene therapy: implications for platelet vessel wall interactions (2002) (0)
March 12, 2002 Rapid Access Publication (2002) (0)
398 Transendocardial injection of mesenchymal stem cell reduces the amount of fibrosis and related heart failure in a dog acute ischaemia model (2004) (0)
Progression of membrane permeability alterations induced by hypoxia in isolated cardiac muscle (1977) (0)
Perioperative myocardial infarction diagnosed by /sup 99m/Tc stannous pyrophosphate myocardial scintigrams (1976) (0)
Prevention and control of ventricular arrhythmia. (1980) (0)
Cyclic flow alterations and neointimal proliferation following experimental coronary stenosis and endothelial injury (1993) (0)
Influence of Hypertonic Mannitol (2005) (0)
Platelets, platelet-derived mediators, endothelial injury, and abrupt and/or progressive stenosis of coronary arteries (1988) (0)
Stem cell therapy in heart disease (2007) (0)
Abstract 15663: A Novel Strategy for Increasing Myocardial Retention of Stem Cells Delivered by Intracoronary Infusion in a Porcine Model of Acute Myocardial Infarction (2011) (0)
Influence ofMannitol on Maintaining Coronary FlowsandSalvaging Myocardium during Ventriculotomy andduring Prolonged Coronary Artery Ligation (1977) (0)
In memoriam: Mavis P. Kelsey, Sr. (1912-2013). (2014) (0)
December 4, 2001 (2001) (0)
Our thanks to reviewers in 2011 (2011) (0)
Our thanks to reviewers in 2007 (2007) (0)
Improvement in myocardial blood perfusion, symptoms and exercise capacity at eight weeks in a controlled study of autologous bone marrow cell transplant in humans with severe ischemic heart failure (2003) (0)
Buying new soul. (2012) (0)
Maintenance of mouse spleen in organ culture and assessment of certain functional capabilities. (1975) (0)
In Memoriam: Philip Poole-Wilson 1943–2009. (2009) (0)
In Memoriam: John Timothy Bricker (1952–2013). (2013) (0)
Abstract: 999 CLUSTERIN-TRANSDUCED CARDIAC STEM CELLS ENHANCES POST-INFARCT CARDIOVASCULAR TISSUE REPAIR (2009) (0)
Acute Coronary Heart Disease Syndromes (0)
In Memoriam: Denton A. Cooley, MD (1920–2016) (2017) (0)
Prostaglandins and lschemic Heart Disease (1991) (0)
Introduction to 50th Anniversary Celebration Issue for Circulation (2000) (0)
[Myocardial scintigraphy in the evaluation of patients with myocardial infarction]. (1982) (0)
Myocardial Imaging with Thallium-201 and Technetium-99m-Pyrophosphate in the Coronary Care Unit: Conclusion (1980) (0)
Images in Cardiovascular Medicine Aneurysm of the Abdominal Aorta (2001) (0)
Addendum : Implementation of Scientifically Proven Treatments I . Complex Systems Analysis for Clinical Application of Scientific Data (2002) (0)
CIRCULATION'S NEWEST FEATURE!!! ONLINE SUBMISSION AND PEER REVIEW IS NOW AVAILABLE (2003) (0)
Proceedings of the National Heart, Lung, and Blood Institute Workshop on Hemostasis, Thrombosis, and Cardiovascular Diseases. Overview and research opportunities. (1992) (0)
Comparison of scintigraphic count-volume and geometric methods for measuring left ventricular ejection fraction (1978) (0)
Abstract 15719: Deletion of Desmoplakin, a Gene Responsible for Arrhythmogenic Cardiomyopathy, Specifically in Cardiac CSPG4pos Cells Leads to Cardiac Arrhythmias and Premature Death (2016) (0)
Images in Cardiovascular Medicine Pulmonary Venous Aneurysms in Hereditary Hemorrhagic Telangiectasia Detected by 3-Dimensional Magnetic Resonance Angiography (2003) (0)
June 8, 2004 (2021) (0)
December 23/30, 2003 (2003) (0)
768-1 Coronary Lesion Histology in Stable, Unstable and Evolving Angina Pectoris (1995) (0)
Racial Disparities in CD34+ Cells and Their Influence on Cardiovascular Repair (2018) (0)
Controversies in cardiology. Proposed: exercise testing and training are beneficial after myocardial infarction. (1983) (0)
Technetium 99m stannous pyrophosphate myocardial scintigraphy to detect myocardial necrosis. (1977) (0)
April 13, 2004 Notice of Editorial Office Transition (2004) (0)
Doctor, Stay by Me: A Medical Memoir (2020) (0)
A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial (2020) (0)
pH as a marker of plaque activity: a possible technique for pH based detection of vulnerable plaque : Tania Khan, Babs Soller, S Ward Casscells, James Willerson and Morteza Naghavi (2004) (0)
December 9, 2003 (2003) (0)
April 1, 2003 (2003) (0)
March 26, 2002: rapid access publication. (2002) (0)
Effect of isoproterenol on regional coronary flow following right ventriculotomy (1976) (0)
P roclaim Pilot Study to Examine the Effects of Clopidogrel on Inflammatory Markers in Patients with Metabolic Syndrome Receiving Low-Dose Aspirin ben-ClinicalInvestigation (2009) (0)
Abstract 16882: Temporal Changes in the Peripheral Blood Mononuclear Cell Populations After Acute Myocardial Infarction and Prediction of Improvement in Left Ventricular Function in the Cardiovascular Cell Therapy Research Network (CCTRN) TIME and Late-TIME Trials (2018) (0)
Thrombolytic therapy for patients with acute myocardial infarction. (1987) (0)
The Editor's Roundtable: Health reform and its implications for cardiovascular medicine. (2010) (0)
Radionuclide ventriculography to evaluate myocardial function. (1983) (0)
Abstract 16657: MicroRNA-184 is Epigenetically Silenced by CpG Methylation and Contributes to the Pathogenesis of Arrhythmogenic Cardiomyopathy Phenotype (2015) (0)
RADIOCHEMISTRy AND RADIOPHARMACEUTICALS Technetium-Labeled Heparln: Preliminary Report of a New Radlopharmaceutlcal with Potential for Imaging Damaged Coronary Arteries and Myocardlum (2006) (0)
Measurement of Myocardial Blood Flow Using 133Xe (1977) (0)
Congestive heart failure in a 70-year-old man. (1993) (0)
In Memoriam: Baruj Benacerraf (1920–2011) (2012) (0)
December 4, 2001: Rapid Track for Review and Publication (2001) (0)
Reply (1978) (0)
Human Adipocytes: Linking Obesity to Vascular Inflammation Release of C-Reactive Protein in Response to Inflammatory Cytokines by (2011) (0)
Coronary Artery Anomalies (2002) (0)
Specific Platelet Mediators and the Abrupt Progression of Coronary Artery Stenoses (1992) (0)
James Willerson: leading the Texans' fight against heart disease. Interview by Ruth Williams. (2012) (0)
Cardiovascular Medicine + DVD (2007) (0)
February 5, 2002: Rapid Access Publication (2002) (0)
Plaque inflammation in atherosclerotic rabbits can be identified by SPIO; introducing a noninvasive method for imaging macrophage infiltration in active and inflamed vulnerable plaque (2002) (0)
Abstract 2799: Noninvasive Quantification of the Atherosclerotic Aorta Component with Flat-Panel Computed Tomography in Rabbits (2008) (0)
ATVB in Focus Noninvasive Assessment of Atherosclerosis: from Structure to Function (2004) (0)
Abstract 13214: A Small Molecule Integrin Agonist Enhances Progenitor Cell Adhesion to Key Homing Receptors for Regenerative Therapy (2010) (0)
In Memoriam: Mark E. Josephson, MD (1943–2017) (2017) (0)
Rapid Track for Publication (2001) (0)
February 12, 2002: Rapid Access Publication (2002) (0)
December 2, 2003 (2003) (0)
THI Cardiology Honors Ceremony: We Wish You Godspeed (2013) (0)
Cardiology: New (1998) (0)
Texas Heart Institute Medal and The Ray C. Fish Award for Scientific Achievement in Cardiovascular Diseases. (2010) (0)
f3-Adrenergic Receptors, Adenylate Cyclase, and Cyclic AMP Concentrations During Acute Myocardial Ischemia and Reperfusion (2005) (0)
Physiological Mechanisms of Atrially Induced Heart Rate Turbulence (2016) (0)
May 21, 2002: Rapid Access Publication (2002) (0)
Safety of autologous bone marrow cell injection in humans with severe ischemic heart failure (2003) (0)
Abstract 053: Carbaprostacyclin Promotes Vascular Growth in Mouse Hindlimb Ischemia (2013) (0)
S. Ward Casscells, MD: 1952–2012 (2013) (0)
Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial Interventions for Bifurcation Lesions in the Recent Era: A Report From the Nine-Month Outcome of Patients Treated by Percutaneous Coronary (2011) (0)
Inflammation and Cardiovascular Disease (2003) (0)
OTAL LEUKOCYTE COUNT AS A ISK FACTOR IN SUBJECTS FREE OF CHD (2016) (0)
Dipyridamole thallium scintigraphy and prognosis in coronary artery disease. (1990) (0)
thrombosis after tissue-type plasminogen activator in a canine model of coronary reocclusion antagonists markedly enhances thrombolysis and prevents or delays Simultaneous administration of thromboxane A2- and serotonin S2- receptor (2011) (0)
Abolition of coronary thrombosis by local application of an E-, P-, and L-selectin inhibitor (1996) (0)
Pathophysiology of persistently positive myocardial scintigrams. (1979) (0)
Cardiac Involvement in Skeletal Myopathies and Neuromuscular Disorders (2007) (0)
Mechanisms contributing to the abrupt conversion from stable to unstable angina and myocardial infarction (1996) (0)
Regenerative Medicine/Injured Human Hearts (2018) (0)
May 7, 2002: Rapid Access Publication (2002) (0)
Mechanical and surgical interventions for the reduction of myocardial ischemia. Discussion. (1976) (0)
Myocardial perfusion scintigraphy and value in patients with non-ST segment elevation acute coronary syndromes. (2009) (0)
Indirect assessment of coronary artery bypass grafts (1972) (0)
Iodine-123-labeled radiotracers for cardiovascular and testicular imaging studies: labeling of phenyl fatty acids for myocardial studies, fibronectin for thrombus localization, and human chorionic gonadotropin for testicular studies (1985) (0)
Buja and Willerson Role of Inflammation in Coronary Plaque Disruption 505 plaques precipitating coronary thrombosis (2005) (0)
Abstract 473: Genetic Fate Mapping Identifies Second Heart Field Epicardial Progenitor Cells as a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy (2008) (0)
February 19, 2002 Rapid Access Publication (2002) (0)
Cardiovascular News Images in Cardiovascular Medicine Life-Threatening Neonatal Arrhythmia Successful Treatment and Confirmation of Clinically Suspected Extreme Long QT-Syndrome-3 (2004) (0)
Abstract 3176: Molecular Imaging of Mesenchymal Stem Cell Following Myocardial Infarction: Evidence for Transdifferentiation (2009) (0)
Cardiovascular News Cardiology Patient Page Platelets and Cardiovascular Disease (2003) (0)
In Memoriam: Howard E. Morgan (1927–2009) (2009) (0)
Reserpine in Raynaud's Disease and Phenomenon (2020) (0)
Hematologic Disease and Heart Disease (2007) (0)
Spleen of Mice and Rats Endotoxin in Liver and Salmonella enteritidis Subcellular Localization of (2013) (0)
Notice of Editorial Office Transition (2004) (0)
Toward the further contributions of Circulation. (1999) (0)
August 27, 2002 Circulation’s Newest Section (2002) (0)
January 15, 2002 Rapid Access Publication (2002) (0)
In Memoriam: Kanu Chatterjee, MD (1934–2015). (2015) (0)
Bone Marrow Cell Characteristics Associated with Patient Profile and Cardiac Performance Outcomes in the LateTIME-CCTRN Trial (2016) (0)
Healthcare's Rubik's Cube (2004) (0)
Regenerative Medicine and the Cardiovascular System: A Good Start* (2015) (0)
Abstract 20853: Knock Down of Activated FOXO Transcription Factors in the Heart in the Lamin Null Mice Attenuates the Phenotype and Prolongs Survival (2017) (0)
Clinicopathological Conference Congestive Heart Failure in a 70-Year-Old Man (0)
October 22, 2002 Circulation’s Newest Section (2002) (0)
Is there a need for additional means of recognizing myocardial necrosis? (1977) (0)
Understanding the Basics of Stem Cells (2006) (0)
Mesenchymal stem cells favor matrix remodeling in a canine myocardial infarction model (2007) (0)
February 4, 2003 (2003) (0)
Reproducibility of centralized laboratory interpretations of measures of myocardial infarct size, ventricular function, and ventricular electrical instability scintigraphy (1991) (0)
In Memoriam: Philip D. Henry (1935–2013) (2013) (0)
SAI-11: WWW.VulnerablePlaque.ORG: prototype of a research-dedicated web site (2001) (0)
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1 (2018) (0)
Expedited Publication of Accepted Manuscripts in Circulation (2001) (0)
Book ReviewDiagnosis and Therapy of Coronary Artery Disease (1980) (0)
Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart€Failure (2018) (0)
I. Pharmacologic and Device Approaches to Prevent Restenosis: Clinical Design and Regulatory Issues (1990) (0)
Clopidogrel prevents platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries (1991) (0)
GADONANOTUBES AS MAGNETIC NANOLABELS: A POWERFUL AND SAFE APPROACH FOR STEM CELL DETECTION (2010) (0)
Influence of hypertonic mannitol on collateral coronary blood flow during acute coronary insufficiency. (1973) (0)
Abstract 16161: Bone Marrow Characteristics are Associated With Changes in Infarct Size Following STEMI: A Biorepository Evaluation From the CCTRN TIME Trial (2014) (0)
How reliable is myocardial imaging in the diagnosis of acute myocardial infarction? (1983) (0)
April 6, 2004 (2004) (0)
196 ARTERIOSCLEROSIS VOL 9 , No 2 , MARCH / APRIL 1989 Methods New Zealand White (2005) (0)
Abstract 515: Mechanical Dyssynchrony Measured by Gated Single Photon Emission Computed Tomography Phase Analysis Predicts Ventricular Remodeling After Acute ST-Elevation Myocardial Infarction (2009) (0)
Comprar Cardiovascular Medicine + DVD | Jay N. Cohn | 9781846281884 | Springer (2007) (0)
Stem Cell Therapy for the Treatment of Heart Failure (2007) (0)
Abstract 16354: Improved Myocardial Function in Patients with Chronic Ischemic Heart Disease Treated with Transendocardial Delivery of Bone Marrow Mononuclear Cells Depends Upon Input Cell Phenotype and Function (2012) (0)
Ventricular tachycardia. (1970) (0)
Mobilization of angiogenic monocytes in response to induced remote ischemia in healthy subjects (2013) (0)
Cardiovascular News Images in Cardiovascular Medicine "Petrified" Right Ventricle in Long-Standing Naxos Arrhythmogenic Right Ventricular Cardiomyopathy (2001) (0)
Thallium 201 myocardial scintigraphy and exercise testing in patients prior to and following coronary artery revascularization. (1981) (0)
In Memoriam: S. Ward Casscells III 1952–2012 (2012) (0)
Images in Cardiovascular Medicine Diagnosis of an Intracoronary Thrombus With Intravascular Ultrasound (2000) (0)
Imaging in electrical cardiac devices. (2011) (0)
Clinical Utilization of Stem Cells in Cardiovascular Diseases (2006) (0)
In Memoriam : Donald G. Rochelle (1931–2009) (2009) (0)
Quantitation of experimental canine myocardial infarct size with technetium stannous pyrophosphate: A comparison of multipinhole and rotating slant hole emission tomography (1981) (0)
Noninvasive evaluation of myocardial perfusion with use of technetium-99m teboroxime. (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James T. Willerson?

James T. Willerson is affiliated with the following schools:

James T. Willerson's Academic­Influence.com Rankings

Why Is James T. Willerson Influential?

James T. Willerson's Published Works

Published Works

What Schools Are Affiliated With James T. Willerson?

James T. Willerson's AcademicInfluence.com Rankings